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CHAPTER 1 
Introduction 

INTRODUCTION 
General introduction 
The vertebrate eye lens is a highly specialized, perfectly transparent organ with 
the refractive ability to focus incoming light onto the retina. The lens is almost 
completely composed of a single cell type, lens fiber cells, which arise from an anterior 
monolayer of epithelial cells. Throughout life, the epithelial cells divide, mainly at the 
lens equator, and start to migrate, elongate and differentiate into fiber cells, which 
overlay the existing cell mass. Shortly after elongation begins, cell nuclei and other cell 
organelles are lost, presumably minimizing the light scattering in the lens. Due to this 
process, there is hardly, if any, protein synthesis and protein turnover in the central 
part of the lens. New protein appears only at the periphery contributing to cell growth. 
Since lenticular cells are never lost, the cells in the lens nucleus contain proteins that 
are as old as the animal itself (for reviews: Bloemendal, 1961; Piatigorsky, 1981; 
Harding and Crabbe, 1984; Maisel, 1985). 
Lens transparency and proper light refraction require a very high protein 
concentration and a very close and regular packing of the proteins. The major classes 
of structural proteins, making up more than 90% of the proteins in the lens, are the 
crystalline. Based on size, charge and immunological properties, three major groups of 
crystallins have been distinguished. The a-, ß-, and κ-crystallins are found in the lenses 
of all vertebrate classes examined, although p-crystallin is low or absent in birds. Some 
restricted taxonomie groups contain additional crystallins, the so-called taxon-specific 
crystallins. These proteins are related or even identical to enzymes, and apparently 
have been recruited as structural proteins by the lens. The best studied is ¿-crystallin, 
specific for avian and reptilian lenses, which is identical to the enzyme 
argininosuccinate lyase (for reviews: Wistow and Piatigorsky, 1987, 1988; de Jong et 
al., 1989; Piatigorsky and Wistow, 1991). 
Bovine lens crystallins 
Very abundant in the eye lenses of bovine and almost all other vertebrate 
species is σ-crystallin. This protein occurs as a large water-soluble aggregate with an 
avarage molecular mass of 800 kDa. The aggregate is composed of two types of 
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primary gene products, σΑ- and αβ-crystallin (173 and 175 amino acid residues, 
respectively), and a variety of posttranslational modifications thereof. The two subunits 
show approximately 57% sequence homology (for review: Bloemendal, 1981; Harding 
and Crabbe, 1984). In rodents and a number of other mammals an additional primary 
gene product, a A'"', resulting from alternative splicing, forms part of the aggregate 
(King and Piatigorsky, 1983; van den Heuvel et al., 1985; Hendriks étal., 1988). 
Until 1989, it was generally accepted that σ-crystallins are strictly lens-specific. 
However, since that time, it has been discovered that σθ-crystallin occurs in a 
multitude of cells, including heart, lung, spinal cord, striated muscle, brain, kidney and 
retina (Bhat and Nagmeni, 1989; Iwaki ef al., 1990; Longoni et al., 1990; Kato et al., 
1991 a). Interestingly, increased levels of oB-crystallin have been observed in various 
neurological disorders (Iwaki ef al., 1989, 1990; Renkawek et al., 1992) and it has 
been shown that oB-crystallin is a major component of ubiquitinylated inclusion bodies 
in a number of human degenerative diseases (Lowe et al., 1992). In these inclusions, 
oB-crystallin is tightly associated with intermediate filaments and ubiquitin (Tomokane 
et al., 1991). Recently, Kato and coworkers (1991b) were able to detect small amounts 
of oA-crystalhn in rat spleen and thymus. Both σΑ- and σΒ-crystallin are homologous to 
the ubiquitous small heat shock proteins (Ingolla and Craig, 1982; de Jong et al., 
1989). The finding that οβ-crystallin can be induced by heat stress (Klemenz et al., 
1991) or hypertonic stress (Dasgupta et al., 1992), is consistent with being a member 
of the small heat shock protein family. Recently, in vitro experiments have 
demonstrated that both σΒ-crystallm and mouse HSP27 can act like molecular 
chaperones. Both proteins protect against heat-induced protein aggregation and enable 
proper refolding of chemically denaturated proteins (Horwitz, 1992; Merck et al., 1993; 
Jakob et al.. 1993). 
There is no direct information about the tertiary structure of the σ-crystallin 
polypeptides, but based on intron positions and intrachain sequence similarities, a two-
domain structure has been proposed, with each domain consisting of two similar 
structural motifs (Wistow, 1985). A C-termmal arm is supposed to extend from the 
two-domain structure. 
The B-crystalhn family is the most heterogeneous group of crystalline, consisting 
of at least seven primary gene products and posttranslational modifications thereof. 
Their subunit size ranges from 23-33 kDa and they are present in the lens as oligomers 
varying from dimers (ßL-crystallin) to octamers (ßH-crystallin). Based on their isoelectric 
point and the presence of N- and/or С-terminal extensions, they can be divided into the 
'acidic' (ßA1, ßA2, ßA3, ßA4) and the 'basic' (ßB1, ßB2, ßB3) ß-crystallins (Berbers ef 
al., 1982). 
The K'Crystallms are exclusively monomeric, with a molecular mass of 
approximately 20 kDa. The κ-crystallins are related to the ß-crystallins, together 
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forming a Вк-superfamily. The first observation which led to this idea was the finding of 
Dnessen et al. (1980), that the QBp chain (BB2) was internally duplicated and showed 
homology with the κ-crystallin family. X-ray crystallographic analysis of the calf yB-
crystallin monomer (Blundell et al., 1981) and the BB2-crystallin dimer (Bax et al, 
1990) has resulted in detailed knowledge of the three-dimensional structure. It was 
found that the B- and the κ-crystallins are both built up of two globular domains, each 
folded in two symmetrically organized Greek key motifs, linked by a connecting 
peptide. However, the conformation of the connecting peptides is quite different in 
these crystallins As a result, the domain interactions in the homodimer of ßB2 are 
antiparallel and intermolecular instead of intramolecular as in κ-crystallin (Lapatto et al., 
1991) Another difference between the two crystallin families is the presence of N-
and/or C-terminal extensions in the ß-crystallms, which do not occupy fixed positions 
(Lapatto et al., 1991, Carver et ai, 1993). Based on the sequence homology and the 
shared four motif/two domain folding pattern of the ß- and κ-crystallins, it is clear that 
these proteins derive from a common ancestor (for review Lubsen et al., 1988). 
Aging of the crystallins 
As a result of its unique development and protein metabolism, the lens is 
extremely useful for studying structural and functional aspects of in vivo aging of 
intracellular proteins. During the aging process there is a progressive conversion of 
protein from the water-soluble to the water-insoluble form. In bovine lenses, mainly a-
crystallin is involved (Pierscionek and Augusteyn, 1988). It was found that the size of 
σ-crystallin aggregates in the lens increases on aging, forming the so-called high 
molecular weight aggregates, which may represent intermediates in the insolubilization 
process (Spector et al, 1971, Liem-The and Hoenders, 1974). The increase of ßH-
crystallin relative to ßL-crystallin has also been attributed to age-related aggregation 
(van Kamp and Hoenders, 1973). 
Upon aging, lens proteins accumulate a multitude of posttranslational 
modifications, both enzymatic and non-enzymatic. The modifications include 
phosphorylation, glycosylation, glycation, carbamylation, oxidation, deamidation, 
isomenzation, racemization, truncation and disulfide and non-disulfide crosslinking (for 
reviews Harding and Dilley, 1976, Hoenders and Bloemendal, 1981; Zigler and 
Goosey, 1981; Hoenders and Bloemendal, 1983; de Jong et al, 1988; Harding, 1991). 
Many of these modifications lead to changes in charge and in size, and to some 
conformational changes as well The involvement of crosslinked polypeptide chains in 
the insolubilization process has been established, and also glycation may be important 
in the formation of water-insoluble protein (Ortwerth et al., 1993). These age-related 
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processes can end up with the opacification of the normally transparent lens, resulting 
in cataract, the most common cause of blindness worldwide (for reviews: Hoenders 
and Bloemendal, 1981; Harding and Crabbe, 1984). 
Outline of this thesis 
In order to contribute to understanding the effects of protein changes in the lens 
on its transparency, we have investigated the alterations in lens proteins that result 
from posttranslational modifications due to aging of the lens 
Previous studies have shown that σ-crystallin undergoes a multitude of 
posttranslational modifications. We studied the racemization of individual aspartyl 
residues in bovine σΑ-crystallin and found one site to be preferentially racemized 
(Chapter 3). In bovine oB-crystallin, we determined the in vivo deamidation site 
(Chapter 4). Both racemization and deamidation reactions are assumed to proceed non-
enzymatically via intramolecular succmimide formation 
Glutamine-lysme crosslinks, which arise by the action of a Ca:+-activated 
transglutaminase, are found in the lens upon aging and they are implicated in the 
development of senile cataract Chapters 5 to 9 deal with the characterization of 
amine-donor (lysine) substrates of transglutaminase Using a newly-developed amine-
acceptor peptide, we were able to identify the bovine lens crystalline that specifically 
function as amine-donor substrates. These are σΒ-crystallin and ßBI-, ГІАЗ- and BA4-
crystallin (Chapters 5 and 7) Like σΒ-crystallin, the related mouse small heat shock 
protein (HSP25), was found to be a substrate for protein crosslinking by 
transglutaminase (Chapter 6) The amine-donor substrate specificity of tissue 
transglutaminase was studied by determining the lysine substrate sites in σβ-crystallin, 
HSP25 and ßA3-crystallin (Chapters 5, 6 and 8), and by mutagenesis of oA-crystallin 
(Chapter 9) 
A survey of the most important site-specific in vivo posttranslational 
modifications and in vitro modifications that have been established for lens crystalline, 
is given in Chapter 2. 
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CHAPTER 2 
Site-specific in vivo and in vitro modifications of lens crystalline 

SITE-SPECIFIC IN VIVO AND IN VITRO MODIFICATIONS OF LENS CRYSTALLINS 
Lens proteins become altered in a variety of ways during aging and 
cataractogenesis. The most important site-specific posttranslational modifications of 
the bovine crystallins and several in vitro modifications that have been established will 
be covered in this section. In addition, the occurrence of these site-specific 
modifications is discussed with regard to the structure and function of the crystallins. 
Deamidation, Isomerization and Racemization 
Deamidation of asparagine residues is thought to be one of the most prevalent 
non-enzymatic posttranslational modifications in aging proteins (Robinson and Rudd, 
1974; Harding, 1985). By changing the local charge, it may affect significantly the 
structural and functional integrity of a protein. 
In vivo age-dependent deamidations have been shown to occur in several 
crystallins. In chicken σΑ-crystallin, residue Asn149 in the sequence Ser-Asn-Met is 
subject to extensive deamidation, whereas the only other asparaginyl residue, at 
position 123, is not affected (Voorter et al., 1987). Similarly, Asn101 in the sequence 
His-Asn-Glu in bovine σΑ-crystallin undergoes deamidation (Fig.1), but not Asn123 
(Voorter et al., 1988). Aged human σΑ-crystallin is deamidated at Asn101 as well 
(Kramps et al., 1978). Bovine σΒ-crystallin deamidates upon aging at Asn146 in the 
sequence Val-Asn-Gly (Fig.1), the only other asparaginyl residue does not (Groenen et 
al., 1993a). 
It is generally accepted that deamidation of asparagine residues in proteins 
occurs via the formation of a succinimide intermediate, which upon ring opening also 
gives rise to isomerization and racemization of the resulting aspartyl residues (Bornstein 
and Balian, 1977; Geiger and Clarke, 1987, Stephenson and Clarke, 1989). In certain 
synthetic peptides, imide ring formation can lead to peptide bond cleavage (Geiger and 
Clarke, 1987; Oliyai and Borchardt, 1993). It has been found that all these succinimide-
mediated processes also occur in vivo during the aging of bovine σΑ-crystallin resulting 
in the deamidation, isomerization and racemization of Asn101, and in the formation of 
the truncated σΑ1101 chain by cleavage after Asn101 (Voorter et al., 1988). 
Imide ring formation can similarly occur at aspartic acid residues, leading to their 
isomerization and racemization (Geiger and Clarke, 1987; Stephenson and Clarke, 
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1989). This process is also inferred to occur in σΑ-crystallin, of which Aspi 51 in the 
sequence Val-Asp-Ala and Leu-Asp-Ala in bovine and human o-A-crvstallin, respectively, 
exhibits pronounced age-dependent racemization (Groenen et al., 1990, FUJI ι et al., 
1991). In bovine oB-crystallin Asp140 and Asn146, in the sequences Ser-Asp-Gly and 
Val-Asn-Gly, respectively, become strongly racemized upon incubation of the protein 
under conditions that favor succinimide formation (Groenen et al., 1993a). 
The rate of succinimide-linked reactions in synthetic peptides is strongly affected 
by the surrounding residues, particularly the amino acids at the carboxylic side of the 
Asx residue In general, the rate of succinimide-linked reactions is decreased as the 
steric bulk of the carboxyl-terminal flanking residue increases (Geiger and Clarke, 1987, 
Stephenson and Clarke, 1989, Patel and Borchardt, 1990; Tyler-Cross and Schirch, 
1991) In native proteins, the propensity of asparaginyl and aspartyl residues to form 
imide rings largely depends on the local conformation and flexibility of the polypeptide 
chain, and on the relative degree of protonation of the aspartyl residues (Clarke, 1987; 
Stephenson and Clarke, 1989; Wright, 1991 a,b, Clarke et al., 1992) Although in vitro 
studies with synthetic peptides indicate that succinimides are short-living intermediates 
(Geiger and Clarke, 1987; Lowenson and Clarke, 1991), a recent study clearly 
demonstrates the presence of a stable succinimide form at the Asp16-Gly17 peptide 
bond of porcine joining peptide (Toney et al, 1993) Direct proof for the presence of 
succinimide intermediates at specific asparaginyl or aspartyl residues that undergo 
deamidation or racemization in lens crystalline, has not yet been provided. 
Deamidation of asparaginyl residues in proteins has been proposed to serve as a 
biological clock that controls the rates of protein turnover, development and aging 
(Robinson and Rudd, 1974, Robinson and Robinson, 1991). Studies of Rogers and 
Rechstemer (1988 a,b,c) indeed indicate that deamidation might be a serious candidate 
for destabilization of proteins, making them more susceptible to proteolytic degradation 
However, other studies indicate the presence of a repair mechanism for altered aspartyl 
residues that arise via deamidation of Asn residues or via succinimide-mediated 
modification of Asp residues It has been proposed that the enzyme protein carboxyl 
methyltransferase (PCMT) would function in a repair mechanism by methylating 
racemized or β isomerized aspartyl residues, which upon demethylation would return to 
the original L-aspartyl residues (McFadden and Clarke, 1982; Clarke, 1985) PCMT-
activity has been demonstrated in bovine and human lenses and lens proteins have 
shown to be very good substrates for this enzyme (McFadden and Clarke, 1986, 
Manna ef al., 1987, Manna et al., 1992) However, the D-Asp content of human lens 
proteins did not decrease upon incubation with PCMT (Manna et al., 1987) indicating 
that the involvement of PCMT in a repair mechanism of racemized aspartyl residues in 
the lens, is unlikely This leaves open the possibility that L-isoaspartyl residues in the 
lens proteins will be repaired In this respect it is noteworthy to note that L-isoaspartyl 
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containing synthetic peptides have been shown to competitively inhibit the methylation 
of D-aspartyl residues in erythrocyte membrane proteins (O'Connor et al., 1984). 
Moreover, studies of Lowenson and Clarke (1992) demonstrated clearly that D-aspartyl 
containing peptides are methylated 1000-10,000 times less efficiently than are their L-
isoaspartyl-containing analogs. This difference in affinities between D-aspartyl and L-
isoaspartyl residues may explain the results of Manna et al. (1987). 
Truncation 
Crystalline undergo intracellular truncation during the aging process in the lens. 
Several truncation products of σ-crystallin have been characterized. σΑ-crystallin is 
processed age-dependently by cleavage at various amino acids in the C-terminal half of 
the molecule (as illustrated in Fig.1) resulting in the polypeptides σΑ1'172 (Emmons and 
Takemoto, 1992), σΑ11Μ, σΑ11Μ (de Jong étal., 1974), σΑΜ51 (van Kleef et al., 1974) 
and σΑ'101 (van Kleef et al., 1976). 
It has been established that the peptide bond cleavage at Asn101 in bovine σΑ-
crystallin giving rise to σΑ1-101, occurs non-enzymatically via imide ring formation 
(Voorter et al., 1988). The peptide bond cleavage at Aspi51 might also proceed non-
enzymatically via a similar mechanism, since degradation via intramolecular cleavage 
can also occur at aspartyl residues (Clarke, 1987; Oliyai and Borchardt, 1993). It has 
been shown that Aspi 51 exhibits pronounced racemization, probably mediated via 
intramolecular imide ring formation (Groenen et al., 1990). Moreover, upon limited 
proteolysis of σ-crystallin no enzymes have been found that bring about the cleavage at 
the Asp151-Ala'52 bond (Siezen and Hoenders, 1979), which also indicates a non-
enzymatic cleavage mechanism. The nearby segment оА15в"1еэ has been shown to be 
very accessible to several enzymes (Siezen and Hoenders, 1979). Whether the 
cleavages at Seri 68, Seri69 and Seri72 occur non-enzymatically or enzymatically via 
endogenous proteinases, is not known yet. 
Bovine σΒ-crystallin is specifically processed at the Thr170-Ala171 bond (Fig. 1 ) 
resulting in the polypeptide σΒ1-170 (van Kleef er al., 1976). Cleavage of this Thr-Ala 
bond can be established in vitro by six different endopeptidases (Siezen and Hoenders, 
1979) indicating that the Thr170-Ala171 bond is proteolytically very labile. Also calpain, a 
Ca2+-dependent proteinase that has been shown to be present in bovine lenses 
(Yoshida et al., 1984), can bring about such cleavage. Calpain cleaves σΒ-crystallin at 
the carboxyl sides of Arg163 and Thr170, and the σΑ-crystallin at the carboxyl sides of 
Seri 62 and Arg163 (Yoshida et al., 1986). The poor correspondence between the four 
sites of cleavage by calpain and the main cleavage sites in vivo makes it unlikely that 
calpain is responsible for the age-related degradation of bovine σ-crystallin in vivo, 
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especially as the degradation in vivo continues in the nucleus (van Kleef et al., 1974, 
1976) where no calpain exists (Yoshida et al., 1985). Cleavage at Thr170 could also 
occur non-enzymatically during prolonged dialysis at pH7.3 (van Kleef et al., 1976) 
indicating a non-enzymatic cleavage mechanism. Recently, a novel in vivo truncation 
product of bovine oB-crystallin was described (Russo et al., 1992). This product could 
be identified as the free N-termmal domain of the ofi-chain, with a molecular mass of 9 
kDa The cleavage is supposed to be due to the activity of proteolytic enzymes in the 
lens. 
Like o-crystallin, also ßB1-crystalhn undergoes site-specific degradation in calf 
lens cortex. The truncated BB1b product is derived in vivo from the primary gene 
product ßB1a by removal of a short fragment from the N-terminus (Vermorken et al, 
1977, Zigler, 1978, Berbers et al., 1983) Furthermore, using polyclonal antisera 
specific for N- and C-terminal sequences of the crystallins, it has been shown that 
human ßB2-crystallm becomes truncated upon aging (McFall-Ngai et al, 1986, 
Takemoto et al, 1987). These experiments indicate that human ßB2-crystallin 
undergoes N-terminal cleavage resulting in a 22-23 kDa fragment, which still retains its 
heat-stability. Only recently, David and coworkers (1992, 1993) demonstrated that 
selenite-induced cataract in rat lenses yields specific degraded ß-crystallm polypeptides, 
which are highly insoluble. The degraded crystallins have been identified by sequence 
analysis as ßB1-, ßB3-, BA3/A1- and ßA4-crystalhn, missing 5 to 49 amino acids from 
their N-termini. It was found that partially degraded ß-crystallin polypeptides from 
cataractous lenses contained N-terminal cleavage sites identical to those produced by 
calpain II The amino acids at the cleavage sites were quite variable. The only similarity 
observed was that the N-termini were removed 6 to 9 residues from the start of the ß-
crystalhn globular domains. 
Human K-crystallins also undergo in vivo truncation. In human cataractous 
lenses, a 10 kDa degradation product that specifically binds antisera to human y-
crystalhn, has been demonstrated (Takemoto et al, 1989). Only recently, a 9 kDa yD-
crystallin fragment and a 8 kDa ps-crystalhn fragment were identified in human lenses 
(Srivastava et al., 1992, 1993). Interestingly, in both human yD- and KS-crystallin, the 
cleavage occurred in the peptide that connects the two domains. Nevertheless, in 
human pD-crystallin the Ser-Ser bond at residues 87-88 was cleaved (Srivastava et al., 
1992), whereas in ps-crystallm the Gly-Gly bond at residues 90-91 was cleaved 
(Srivastava et al, 1993). 
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Fig.1 Localization of in vivo and in vitro modifications in o-crystallin 
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Fig 1: 
Localization of in vivo and in vitro modifications in oA- and oB-crystallin. The aligned bovine oA-
and σΒ-crystallin sequences are arranged according to the predicted two-domain structure 
(Wistow, 1985). The first domain comprises residues 1-63, the second domain comprises 
residues 64-144 and the С-terminal extension comprises residues 145-173 of oA-crystalhn 
Modifications are indicated below and above the oA- and oB-chams, respectively; in vivo 
modifications are underlined. Modified amino acids are indicated in bold. 
Symbols are: С = phosphorylation, g = glycosylation, о = oxidation, с = crosshnking (induced 
by photooxidation), d. = deamidation, ' = accompanied by in vivo racemization and isomenzati-
on, r = racemization, i = truncation at the carboxvl side of the ammo acid, t = truncation 
upon in vitro proteolysis, a. = amine-donor substrate for transglutaminase f = increased 
fluoresence emission maximum. 
All tyrosines are modified (indicated in bold) upon lodination, only the most reactive residue is 
indicated (ι). All lysines residues are modified (indicated in bold) upon in vitro 'glycation' in σΑ-
and oB-crvstalhn, and upon acetylation and carbamylation in oA-crystalhn, * = the most 
reactive lysines upon in vitro 'glycation' with ascorbic acid (Lys 11 and Lys 166 of σΑ-chain, 
Lys166, Lys174 and Lys175 of σΒ-chain), in vitro acetylation (Lys166 of σΑ-chain) and in vitro 
carbamylation (Lys11 of oA-cham). 
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Among the lens crystallins only three major polypeptides σΑ-, σΒ- and BB2-
crystallin, are found to be phosphorylated in the bovine lens (Kleiman et al. 1988). The 
in vivo and in vitro site of phosphorylation of bovine σΑ-crystallin has been identified as 
the serine at position 122 (Fig. 1 ) in the C-terminal domain of the polypeptide (Voorter 
et al., 1986; Chiesa et al.. 1987a). Bovine oB-crystallin is phosphorylated in vivo at one 
or two different sites, resulting in a mono- and diphosphorylated σΒ-crystallin chain. 
Phosphorylation can occur at serine residues at positions 19, 45 or 59 in the N-terminal 
domain of the polypeptide (Fig.1), with Ser45 being the major phosphorylated residue 
in the subunit (Chiesa et al., 1987b; Voorter ef al., 1989; Smith et al.. 1992). Although 
bovine σΑ-crystallin contains possible phosphorylation sites (a serine and a threonine 
residue) at corresponding positions of the serines 45 and 59 of σΒ-crystallin, these 
residues are not phosphorylated in σΑ-crystallin. A single phosphorylation site, at 
Ser203, has been identified in bovine ßB2-crystallin (Kleiman et al., 1988). 
The serine sites in bovine a- and ß-crystallins appear to be phosphorylated in 
vitro by a cAMP-dependent protein kinase (Spector et al., 1985; Kleiman et al., 1988) 
and cAMP-dependent protein kinase activity has indeed been demonstrated in the 
bovine lens (Takats et al., 1978). The sequences around the phosphorylation site 
Seri 22 of σΑ-crystallin and around Ser59 of σΒ-crystallin are both RXPSX (Voorter et 
al., 1986; Smith er al., 1992), and the sequence around Ser203 of BB2-crystallin is 
RXXXHPS. Although cAMP-dependent serine kinases with substrate specificity for a 
more general sequence RXXSX have been reported, kinases with specificity for serine 
preceded by proline have not been found (Kemp and Pearson, 1990). A distinct amino 
acid sequence XSPX is associated with the phosphorylation at Seri9 and Ser45 of σΒ-
crystallin. A kinase with the same specificity was isolated from rat pheochromocytoma 
cells (Vulliet ef al., 1989). From the specificity of the phosphorylation sites in the 
crystallins it appears that there may be several kinases responsible for the 
phosphorylation of σ-crystallin. 
In mature lens-fiber cells phosphorylation of σΑ- and σΒ-crystallin is essentially 
irreversible, but dephosphorylation of the serines has been shown to occur in lens 
epithelium (Chiesa and Spector, 1989). A maximum of 30% of the σΑ- and σΒ-chains 
becomes phosphorylated in the bovine lens. In other species, phosphorylation occurs to 
a different extent or is even absent, e.g., in chicken. Phosphorylation of σ-crystallin 
does not seem to affect the ability of the subunits to associate (Augusteyn et al., 
1989). Although the reversible phosphorylation of σ-crystallin suggests it to be subject 
to active metabolic control, the significance of this modification is completely unknown. 
Phosphorylation of the small heat-shock proteins, which are homologous with 
vertebrate σ-crystallins, is more evidently subject to metabolic control. Mammalian heat 
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shock proteins exhibit rapid phosphorylation in response to heat shock or chemical 
stress (Landry et al., 1992). Human HSP27 is phosphorylated at three sites identified 
as Seri5, Ser78 and Ser82, with the last one being the major site (Landry et al., 
1992). All sites are located within a common sequence motif RXXS, which is the 
recognition motif for multifunctional calmodulin-dependent protein kinase II and 
nbosomal protein S6 kinase II (Kemp and Pearson, 1990). Recent studies show that a 
distinct heat shock- and serum-induced serine protein kinase may be responsible for the 
phosphorylation of small heat shock proteins (Zhou et al., 1993). Another group, 
however, has identified the MAP kinase-activated protein kinase-2 (MAPKAP kinase-2) 
as the major enzyme that phosphorylates the small heat shock proteins (Stokoe et al., 
1992) This MAPKAP kinase-2 is itself activated by the heat-shock inducible MAP 
kinase activity (Chung et al., 1992). 
Since σ-crystallins are present in nonlenticular tissues (Bhat et al., 1989; Kato et 
al, 1991), where they appear to have important functions unrelated to their structural 
role in lens tissue (for reviews, see Wistow and Piatigorsky 1988; Piatigorsky and 
Wistow 1989), it would be interesting to examine the phosphorylation of σΑ- and σΒ-
crystallin upon stress 
Glycosylation 
0-hnked N-acetylglucosamine (O-GlcNAc) is a recently identified form of 
glycosylation occurring in intracellular proteins An in vitro enzymatic assay, using 
bovine milk galactosyl-transferase that transfers [3H]Gal to terminal GlcNac moieties, 
provided evidence that σΑ- and σΒ-crystallin in the lenses of man, rhesus monkey, rat, 
cow and rhea are modified with 0-linked N-acetylglucosamine (Roquemore et al., 
1992) Protein sequencing and fast atom bombardment-mass spectrometry of tryptic 
peptides from bovine oA-crystallin showed the major site of glycosylation to be Seri 62 
in peptide T19 with the amino acid sequence AIPVSR (Fig.1). The corresponding 
sequence in σΒ-crystallin is TIPITR, with Thr158 and Thr162 being potential sites for 0-
GlcNAc attachment However, FAB-MS analysis did not reveal detectable glycosylation 
of oB-crystallin at Thr158 or Thr1 62. 
It has been postulated that O-GlcNAc is a regulatory modification analogous to 
phosphorylation or, alternatively, that it may be involved in the organization of 
multiprotem complexes (Holt era/., 1987; Kearse and Hart, 1991). The significance of 
this modification for the structure and function of σ-crystallin, in and outside the lens, 
is not clear. 
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Glycation 
All bovine lens crystalline undergo nonenzymatic glycosylation (glycation) by 
forming covalent linkages with glucose and other sugar aldehydes via the Maillard 
reaction (Stevens et al., 1978; Monnier et al.. 1981; Perry et al.. 1987). During this 
glycation reaction the sugar aldehyde group reacts with the e-amino group of lysines or 
with the σ-amino group of a protein, to form a reversible Schiff base, which upon 
Amadori rearrangement yields a stable ketoamme structure, commonly called the 
Amadon product There is good evidence that glycation of the structural lens crystalline 
leads to conformational changes and to partial protein unfolding (Beswick and Harding, 
1987a), allowing the oxidation of newly-exposed thiols to disulfides, which act as 
crosslinks (Beswick and Harding, 1987b). Crystallin aggregation can also occur through 
advanced glycation-mediated protein crosslmking (Monnier and Cerami, 1981; Swamy 
et al., 1993). As these modifications could impair lens transparency, they are 
implicated in the development of cataract, both in diabetics and in non-diabetics 
(Harding, 1981, Harding, 1991). 
Glycation of lens proteins has been shown to increase upon aging and in 
diabetes (Chiou et al., 1981, Rao and Cotlier, 1986; van Boekel et al., 1992). In 
streptozotocin-induced cataracts in rats and during in vitro glycation studies, it was 
found that K-crystallin is most readily glycated as compared to other crystalline (Swamy 
and Abraham, 1991). The major site of reaction of glucose-6-phosphate with bovine 
ИІ-crystallin has been identified as the σ-amino group of the N-terminal glycine (Harding 
er al., 1989) This modification leads to alteration of the protein tertiary structure, as 
manifested by near-UV CO spectroscopy (Beswick and Harding, 1987a). Binding of 
glucose-6-phosphate to bovine σ-crystalhn also induces conformational changes, which 
affect the tertiary and quaternary structure of σ-crystallin (Beswick and Harding, 
1987a). 
While several sugars can participate in glycation, there is evidence that the 
autooxidation products of ascorbic acid can also rapidly glycate and crosslink lens 
proteins (Slight er al., 1988, Prabhakaram and Ortwerh, 1992). Because ascorbic acid 
is present at high concentrations in the lens (Kern and Zolot, 1987) and because 
oxidative conditions are known to exist in cataractous lenses (Garner and Spector, 
1980), this may be a significant reaction in cataract. In vitro incubation of bovine a-
crystallin with '"C-ascorbic acid, followed by analysis of the chymotryptic peptides by 
mass spectrometry, allowed the identification of the sites and the extent of 
modification (Ortwerth ef al., 1992). It was shown that all lysine residues of σΑ- and 
oB-crystallin were modified The values ranged from 6% for Lys78 to 3 1 % and 36% 
for Lys166 and Lys11, respectively, in σΑ-crystallin, and from 5% for Lys82 to an 
average of 38% for the peptide containing Lys166, Lys174 and Lys175 in σΒ-crystallin, 
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as illustrated in Fig.1. The modification pattern was similar for each subunit in that 
Lys78 in σΑ-crystallin and Lys82 in σΒ-crystallin, which are at homologous positions, 
were least reactive. The lysines located at the amino or carboxylic ends of the subunits 
showed a high reactivity, suggesting that these residues are exposed and accessible to 
the reactive species. 
Carbamylation 
The reaction of isocyanate with f-amino groups of lysines or with the σ-amino 
group of a protein, is called carbamylation. Isocyanate is endogenous to the lens 
because it is in equilibrium with urea, which occurs in a certain percentage in the lens 
(Kuck, 1975). Carbamylation of lens proteins may contribute to the high incidence of 
cataract in diseases that are accompanied by elevated levels of isocyanate, like diarrhea 
and renal failure (Harding and Rixon, 1980; van Heyningen and Harding, 1986) The 
reaction of isocyanate with bovine lens σ-crystallin causes changes in the secondary 
and tertiary structure of σ-crystallin with subsequent disulfide bonding and aggregate 
formation that might contribute to opacification (Beswick and Harding, 1984; Beswick 
and Harding, 1987b) 
A recent study on the in vitro carbamylation of bovine σ-crystallin (Qin et al, 
1992) showed that all 7 lysyl residues of σΑ-crystallin are carbamylated, some more 
rapidly than others. The extent of modification varied from 5% for Lys88 to 6 1 % to 
Lys 11 (Fig.1). The range in the extent of modification at different sites likely reflects 
the accessibility of the lysine residues due to the conformation of σ-crystallin in the 
incubation solution 
Acetylation 
Both a- and ß-crystallms are N-termmally acetylated (Dnessen et а!.. 1985). The 
responsible acetylating enzyme that specifically catalyzes the attachment of the acetyl 
group at the σ-amino group has been shown to be present in bovine lenses. In addition 
to NHj-terminal acetylation, the c-amino groups of lysines are subject to acetylation 
Aspirin has been shown to inhibit both the glycation and the carbamylation of lens 
proteins, presumably through acetylation of lysine residues (Crompton era/., 1985; Rao 
et al., 1985, Huby and Harding, 1988, Rao and Cotlier, 1988). Hence, aspirin and 
paracetamol as well, may be used as anti-cataract drugs (Blakytny and Harding, 1992, 
Harding, 1992) 
The acetylation of lysines in bovine σΑ-crystallin has been examined after 
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incubation of whole σ-crystallin with aspirin (Hasan et al., 1993). It was found that all 
7 lysyl residues of σΑ-crystallin reacted with aspirin and a modified cysteme-containing 
peptide was detected as well. The extent of acetylation varied from 10% for Lys88, 
the least reactive, to 60% for Lys166, the most reactive (Fig.1). The relative order of 
magnitude for acetylation and carbamylation is similar, except for Lys11 and Lys 166 
The larger extent of acetylation vs. carbamylation at 166 may reflect the presence of 
two glutamic acids adjacent to Lys 166, which might repel the negatively charged 
isocyanate. The fact that both acetylation (Hasan et al., 1993) and carbamylation (Qin 
et al, 1992) were least reactive at Lys88 suggests that this residue is buried in the 
tertiary structure of σΑ-crystallin. Comparison of the yield of acetylated σ-crystallins 
with the yield of carbamylated σ-crystallins indicated that aspirin is not likely to be an 
effective inhibitor of lysine carbamylation in cataract (Hasan et al., 1993) 
The modification patterns for acetylation and carbamylation differ slightly from 
the modification pattern for ascorbic acid reactivity, which shows a relatively high 
reactivity (24%) of Lys88 (Ortwerth et al., 1992). However, Lys92 of oB-crystallm, 
which is at a corresponding position with Lys88 of οΆ-crystallin, only showed low 
reactivity (16%) towards ascorbic acid On the other hand, the least reactive residue 
towards ascorbic acid modification, Lys78 of σΑ-crystallin, also showed low reactivity 
towards carbamylation (18%, Qin et al., 1992) and towards acetylation (13%, Hasan 
era/, 1993) 
In vitro studies with rat lens crystalline (Cherian and Abraham, 1993) 
demonstrated that young rat κ-crystallin, which is most readily glycated as compared to 
other crystallins, also becomes most readily acetylated by aspirin, thus showing high 
level inhibition of glycation This finding indicates that aspirin can selectively block the 
(high-affinity) sites for glycation No significant acetylation of protein thiols occurred 
during incubation of the crystallins with 10 mM aspirin (Cherian and Abraham, 1993). 
A recent study of Qin et al (1993) shows that not only the amino groups (N-terminus, 
Lys2 and Lys163) but also two cysteine residues (Cys41 and Cys109) in bovine y\\-
crystalhn become acetylated when incubated with 100 mM aspirin Cysteinyl residues 
can also be carbamylated. The carbamylation at the cysteinyl residues is reversible at 
pH 7 4, leading to regeneration of thiol groups and disulfide bonding. In contrast, the 
acetylation at cysteinyl residues is stable and thus can prevent disulfide bonding. 
According to the authors, this difference in stability may explain how cyanate 
promotes, and aspirin inhibits, cataractogenesis. 
From these studies, it is clear that the mode of action of aspirin in inhibiting 
cataract is still unknown Perhaps, the effectiveness of aspirin is due to a mechanism 
other than blocking the glycation or carbamylation sites by acetylation. This is 
supported by the fact that Ibuprofen, which lacks the acetyl group and therefore cannot 
acetylate, also prevents binding of cyanate, galactose and glucosamine to lens proteins 
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(Ajiboye and Harding, 1989, Roberts and Harding, 1990). Ibuprofen may induce a 
conformational change in the protein, preventing metabolites from recognizing the 
binding sites (Roberts and Harding , 1990). An alternative way in which aspirin and its 
substitutes can prevent cataract, is by acting as an aldose reductase inhibitor (Williams 
et al., 19Θ6). When glucose levels are elevated in the lens, this sugar is converted into 
sorbitol by aldose reductase (Cheng et al, 1985). As sorbitol is unable to pass lens cell 
membranes, the osmotic pressure increases dramatically, which could contribute to the 
damagemg of lens fiber cells and the formation of cataract. Aspirin and its substitutes 
might inhibit aldose reductase and thereby the development of cataract. 
Oxidation 
Oxidative modifications of eye lens proteins occur during aging and may 
contribute to the formation of cataract (Augusteyn, 1981; Spector, 1985, Andley, 
1987) These modifications include the selective oxidation of specific amino acids 
(Garner and Spector, 1981) resulting in charge alterations, protein degradation (van 
Kleef et al, 1976, Kr amps et al, 1978), protein crosslinking and insolubilization, and 
increased non-tryptophan fluorescence (van Haard et al, 1978, Bessems et al.. 1987) 
Photooxidation may occur directly, upon absorption of UV-radiation by aromatic side 
chains of the proteins. It can also occur via highly reactive oxygen species, which 
readily oxidize substrate molecules Reactive oxygen species, such as singlet oxygen, 
hydrogen peroxide, superoxide anion and hydroxyl radicals can be generated in the eye 
lens by the exposure to light in the presence of photosensitizers, like riboflavin and the 
kynuremnes (van Heyningen, 1973, Zigman, 1981), or through the Fenton reaction, 
mediated by metal ions (Dillon, 1985, Zigman, 1985). The lens has a number of 
endogenous defense mechanisms against oxidative damage, involving the normal 
degradation of oxidatively damaged proteins and protein fragments (Davies, 1986; 
Davies et al. 1987), and the presence of antioxidant compounds (ascorbate, 
glutathione) and of antioxidant enzymes (catatase, dismutase) (for reviews* Lerman, 
1980, Augusteyn, 1981, Harding, 1981; Dillon, 1985; Zigman, 1985) These 
mechanisms are effective in normal young lenses, but several studies suggest that 
there is a decline in lenticular proteolysis and in antioxidant capacity with increasing 
age, which might be responsible for the accumulation of damaged crystalline and the 
production of insoluble aggregates found in cataractous lenses (Fleshman et al, 1985; 
Taylor and Davies 1987; Carmicheal and Hipkiss, 1989). 
Exposure of bovine lens crystallins to activated oxygen species, generated via 
the Fenton reaction, leads to many modifications that include the formation of non-
disulfide crosslinks in a- and UH-crystallin, peptide cleavage, a loss of the more basic 
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protein species and an increase in the more acidic protein species in α-, β- and y-
crystalhn (Garland et al., 1986). Carmichael and Hipkiss (1989) report the generation of 
specific fragments of bovine σ-crystallin of 15 1 and 16.6 kDa, upon Н2Ог/Си2+-
mediated free radical treatment under degassed conditions. Fe2+-catalyzed oxidation or 
UV-irradiation of bovine σ-crystallin leads to crosslinkmg, producing a 43-kDa 
aggregate, which is composed of both A and В chains of σ-crystallin linked by non­
reducible covalent crosslinks Sequence analysis of a 30-kDa proteolytic fragment 
revealed the presence of one of these crosslinks towards the carboxytermmus after 
Phel 14 and His111 of the A and В chain, respectively (McDermott eia/., 1988, 1989). 
This in vitro generated 43-kDa aggregate may be similar to the 43-kDa aggregate that 
is found in aged and cataractous human lenses (Roy et al., 1984, Spector et al., 1979, 
Spector 1984) 
The effects of singlet oxygen and hydroxyl radical on bovine lens crystalline 
were studied by Balasubramanian et al. (1990) and Guptasarma and Balasubramanian 
(1992) It was found that Trp, Tyr and His residues were readily modified. Trp residues 
were oxidized to N-formylkynurenme and related compounds, but this in itself does not 
lead to covalent aggregation of the protein. Tyr residues react with the active oxygen 
species, but do not produce dihydroxyphenylalanine or bityrosine. Oxidation of His 
residues appears to be obligatory for the formation of high molecular weight protein 
covalent aggregates Lys residues seem to participate in the crosslinkmg reaction 
Reactivity towards the hydroxyl radical (OH) varies in the order o->ß->K-crystallm 
(Guptasarma and Balasubramanian, 1992). It is not clear whether this reactivity reflects 
the order of accessibility of reactive residues in the proteins, since the vulnerability of 
the proteins to modification by singlet oxygen follows the order K->ß->o-crystallm 
(Balasubramanian et al., 1990), whereas the sensitivity to direct photooxidation at 300 
nm varies in the order a->K->ß-crystallin (Andley et al., 1984). 
Photooxidation of кЧ-crystallin by irradiation at 295 nm revealed the formation of 
a 40 kDa crosslinkmg product and a loss in Trp, His, Met and Cys residues (Hott and 
Borkman, 1992) The results indicate that photo-crosshnking occurred between tryptic 
peptides T3, T5 and/or T7, which contain photoreactive residues (His14, Cys15, 
Cys41, Trp42, His53, Trp68 and Met69). 
Photooxidation of calf σ-crystallin with singlet oxygen resulted m the specific 
loss of six peptides from tryptic peptide maps and in the formation of two peptide 
photo-products (P1 and P2) (McDermott et al, 1991) Five of the six modified peptides 
contained photooxidizable residues His, Met and Trp, notably T I , T11, T18 of σΑ-
crystallin and T1 and T4 of oB-crystallin. The sixth modified peptide was T20, 
corresponding with the carboxylterminus of σΑ-crystallin The presence of histidme in 
T11 (His97) and T18 (His154) of σΑ-crystallin, may explain their susceptibility to 
photooxidation The fact that specific histidme residues in σΑ- and σΒ-crystallm are 
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preferentially modified upon photooxidation, suggests that these residues are at the 
surface (hydrophylic region) of σ-crystallin. A major macromolecular change that occurs 
in σ-crystallin upon photooxidation with singlet oxygen is the formation of a non­
reducible 40-kDa crosslink. The results of Dillon et al., (1993) indicate that Lys 166 
(T20) close to the C-terrninal end of the σΑ chain forms a crosslink with the His7 
residue (TD close to the N-terminal end of the σΑ chain, as determined by FAB-MS 
analysis of photo-product P2. FAB-MS analysis of photo-product PI reveals this to be 
an oxidation product of peptide T4 of the oB-chain, in which Met68 is oxidized to Met 
sulfoxide, whereas residue ТгрбО remains intact. These results strongly suggest that 
ТгрбО is buried while Met68 is located near the surface of the B-chain in σ-crystallin. 
The photooxidized residues in σΑ-crystallin: His7, Trp9, His97, His154 and Lys166, 
and in oß-crystallin: Trp9 and Met68, are indicated in Fig. 1. 
Using screening spot blot analysis combined with mass spectrometry, Takemoto 
era/. (1992) provided evidence that the N-terminal methionine of σΑ-crystallin, which is 
N-terminally acetylated, has been oxidized to methionine sulfoxide in vivo (Fig. 1). This 
oxidation of the N-terminal Met, which is exposed on the outside of the polypeptide, 
was found in σΑ-crystallin of foetal bovine lenses and in older bovine lenses. 
Localization of Trp, Tyr and Cys residues in σ-crystallin 
The localization of tryptophan residues in σ-crystallin and in the subunit 
homopolymers was examined by comparing their fluorescence emission properties 
(Hendriks et al., 1990; Augusteyn et al., 1993). These fluorescence measurements 
indicate that the tryptophan residues in rat σ-crystallin, notably Trp9 of σΑ- and σΒ-
crystallín, ТгрбО of σΒ-crystallin and Trp74 of the oAin,-polypeptide, all reside in 
hydrophobic environments (Hendriks et al., 1990). Similar fluorescence emission 
maxima were also found for Trp9 and ТгрбО of bovine σ-crystallin and the 
homopolymers constructed from the σΑ- and σΒ-chains (Augusteyn et al., 1993). 
However, on the basis of differences in fluorescence decay lifetimes and accessibility 
to quenchers, two classes of tryptophan residues could be distinguished. It would 
appear that ТгрбО in the B-chain is more accessible to the solvent and to quenchers 
than the residue at position 9 (in both A- and B-chains). It is concluded that most likely 
residue 9 is located within an hydrophobic domain, possibly at the center of the 
aggregate, whereas residue 60 is closer to the surface (Augusteyn et al., 1993). 
These findings are in contradiction to results from photolysis experiments (Dillon 
ef al., 1987), showing a preferential destruction of Trp9 relative to ТгрбО upon 
irradiation of σ-crystallin (Fig.1). Borkman and coworkers (1993) used these 
photochemical data and the observed changes in fluorescence decay following UV 
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irradiation, to assign the fluorescence decay components in σ-crystallin. This approach 
leads to the assignement of Trp9 as the long-lived decay component (associated with 
solvent-exposed, hydrophilic residues) and ТгрбО as the short-lived decay component 
(associated with hydrophobic residues). 
The accessibility of tyrosine residues in σ-crystallin was studied by 
lactoperoxidase-catalyzed lodination (Hendriks ef al., 1990). It was clearly 
demonstrated that the 6 tyrosine residues in the σΑ-chain (at positions 18, 34, 47, 48, 
109 and 118) and the two tyrosine residues in the σΒ-chain (at positions 48 and 118) 
were all lodinated, but the extent of modification varied greatly. The tyrosine at position 
109 in the σΑ-chain is by far the most accessible for lodination (Fig.1), indicating a 
surface-exposed localization in the σ-crystallin aggregate. The tyrosine residues at 
positions 48 and 118 in the σΑ-and the oB-chain were only poorly labelled. Tyrosine 
ionization in several different σ-crystallins was measured by Augusteyn and coworkers 
(1993). The observed high pKa-values for tyrosine ionization are indicative for residues 
highly shielded from the solvent. However, since Tyr109 lowers the overall pKa for the 
σ-crystallins, it was suggested that this tyrosine residue is exposed to the solvent, 
which is in close agreement with the findings of Hendriks et al. (1990). 
The single σΑ-chain cysteines (at position 131) appear to be located in very 
similar microenvironments, close to the surface of the foetal bovine σ-crystallin 
aggregate (Augusteyn et al, 1987). Age-related conformational changes give rise to 
heterogeneity of this sulphydryl group, as was observed by Siezen et al. (1978). The 
second cysteine in human oA-crystallin, at position 142, is completely exposed 
(Augusteyn et al, 1987). 
Crosslinking 
Crosslinking of crystalline has been reported to occur in the lens with aging and 
cataractogenesis. In addition to the loss of -SH groups and the concomitant formation 
of disulfide crosslinks (Spector, 1985; Yu et al., 1985, Hum and Augusteyn, 1987), 
several nondisulfide crosslinks have been identified in human cataractous lenses These 
include the non-enzymatic bityrosine (Zigman, 1985), lanthionme, a thioether derived 
from cysteine (Bessems et al., 1987) and histidinoalanine crosslinks (Kanayama et al., 
1987), as well as the enzymatically-produced κ-glutamyl-e-lysine crosslinks (Lorand et 
al., 1981). The formation of the latter Gln-Lys crosslinks is accomplished by the Ca2+-
dependent enzyme transglutaminase. This enzyme catalyzes the covalent coupling of 
the K-carboxamide group of peptide-bound glutamme residues with an e-amtno group of 
peptide-bound lysine residues, resulting in intramolecular or intermolecular protein 
crosslinking. Transglutaminase also catalyzes the specific incorporation of amines into 
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proteins and, in fact, this enzyme can be assayed readily in tissues by amine 
incorporation (for review: Folk, 1983). Lenses of various mammalian species have been 
shown to exhibit transglutaminase activity (Lorand et al., 1981). Endogenous proteins 
in the lens serve as substrates for transglutaminase in this tissue, and a general role for 
transglutaminase in lens aging has been implicated, because aged cataractous human 
lenses contain significant amounts of Gln-Lys isopeptide bonds (Lorand et al., 1981). 
In the bovine lens, three ß-crystallin subunits, notably BB2-, BB3- and BA3-
crystallins, have been shown to act selectively as amine-acceptor (Gin) substrates for 
lens transglutaminase (Berbers et al., 1984). This has been established by selective 
incorporation of [3H]-methylamine into these polypeptides. The sites of the labelling 
have been identified, being Gln9 in BB2-crystallin, Gln21 in ВВЗ-crystallin and Gln23/24 
in ВАЗ-crystallin, all located in the N-terminal extensions of these B-crystallms. These 
N-terminal arms apparently provide the correct juxtapositions of substrate glutamines in 
the tertiary structure to make them accessible for lens transglutaminase. The identified 
amine-acceptor substrate sequences do not exhibit any similarity in primary sequence. 
Examination of the amino acid sequences surrounding the reactive glutamine residues in 
substrate proteins outside the lens, does not reveal a consensus sequence for the 
modification either (Aeschlimann et al., 1992). However, a location of these sites at 
the surface of the respective proteins seems to be a common feature, as indicated by 
the high proportion of charged and polar amino acids in the sequences adjacent to the 
amine incorporation site. 
The identification of the amme-donor (Lys) substrates in the bovine lens has 
recently been accomplished using a biotinylated amine-acceptor peptide, modelled on 
the sequence around the amine-acceptor glutamine residue in bovine BA3-crystallin 
(Groenen et al., 1992,1993b) It was demonstrated that three B-crystallms, notably 
BB1-, ВАЗ- and BA4-crystallins, and oB-crystallin serve as amme-donor substrates for 
transglutaminase (Groenen et al, 1993b). The C-terminal lysine residue in bovine σΒ-
crystallin was clearly identified as the only amme-donor substrate (Groenen er al., 
1992; Lorand et al, 1992), as indicated in Fig 1 Mouse HSP27 is also modified by 
transglutaminase and, like in oB-crystallin, the C-terminal lysine was identified as the 
sole amme-donor substrate (Merck et al.. 1993). The identified lysine substrate site in 
ВАЗ-crystallin (Groenen et al., 1993c) and the inferred lysines in BB1-crystallin 
(Mulders et al., 1987; Groenen étal., 1993b) are located in the N-terminal extensions 
of the polypeptides. 
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Modifications and protein structure 
Age-related modifications have most thoroughly been studied in σ-crystallm 
Unfortunately, the tertiary structure of the σ-crystallm subunits is still unknown. 
Attempts to grow σ-crystallin crystals have been unsuccessful until now, thus 
excluding the possibility of X-ray crystallography. However, based on the gene and 
protein structure, a model for the tertiary structure of the σ-crystallin subunits was 
predicted by Wistow (1985) This model proposes a two-domain structure, consisting 
of a globular N-termmal domain of two symmetry-related motifs and a somewhat larger 
C-terminal domain, also with two motifs, with an extended C-termmal region The 
actual organization of the σ-crystallin subunits within the aggregate is still poorly 
understood Not only is the σ-crystallin aggregate composed of two types of primary 
gene products, σΑ and σΒ, but also several posttranslationally modified products form 
part of the aggregate Structural studies are therefore dealing with a rather complex 
protein assembly. Several models for the σ-crystallm quaternary structure have been 
proposed, including three layered models (Bindels et al.. 1979; Tardieu et al. 1986), 
the micelle structure (Augusteyn and Koretz, 1987), the three layer structure in which 
the inner layer is a micelle (Walsh et al, 1991) and the rhombic dodecahedron 
(Wistow, 1993) 
Consideration of the in vivo and in vitro modifications of σ-crystallin, reveals the 
susceptibility of the C-terminal extension of both the σΑ- and the oB-chain towards 
various modifications (see Fig 1, tables 1 and 2). The approximately ten C-terminal 
amino acid residues seem to be most reactive, which is in agreement with the results 
of Carver et al (1993), who demonstrated by NMR-studies that the 8 and 10 C-
terminal residues of σΑ- and σΒ-crystallin, respectively, are extremely flexible 
Modifications were also found in the domain regions of these polypeptides, although to 
a lesser extent. It is noteworthy, that the modification pattern is different for each 
subunit In σΑ-crystallin, the N-terminal residues (1-11) are quite vulnerable to 
modifications, but the remaining residues in the first domain are not. In σΒ-crystallin, 
specific residues within the entire first domain undergo modifications, notably oxidation 
and phosphorylation Although oA-crystallin contains potential phosphorylation sites at 
corresponding positions of the phosphorylated serines in σΒ-crystallin, this polypeptide 
is phosphorylated in the second domain. 
Besides this difference, σΑ- and σβ-crystallin share some similarities with 
respect to the modification pattern too. In both crystalline, peptide bond cleavage 
occurs in the C-terminal extension but also in the middle of the protein sequence. The 
free N-terminal domain (molecular mass 9 kDa) of oB-crystallin was recently identified 
as an in vivo degradation product (Russo et al, 1992) In σΑ-crystallin, peptide bond 
cleavage occurs at Asn101, resulting in a protein fragment of about 10 kDa (van Kleef 
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et al., 1976). This asparaginyl residue is located close to the putative connecting 
peptide (residues 102-104; Wistow, 1985) between two structural motifs. Yet, the 
flanking residue HislOO does not undergo photooxidation, whereas His97 does 
(McDermott et al.. 1991). The modification pattern towards in vitro 'glycation' with 
ascorbic acid was also quite similar in both σ-crystallin subunits (Ortwerth et al., 1992). 
Lys78 in σΑ-crystallin and Lys82 in aB-crystallin, which are at homologous positions, 
were the least reactive lysine residues of both polypeptides. This may reflect a buried 
localization in the tertiary structure. 
Although the posttranslational modifications in o-crystallin give additional or 
confirmative information about the tertiary structure of the σ-crystallin polypeptides, 
they probably do not give enough information to support a particular model for the a-
crystallin quaternary structure. The different localizations of the phosphorylation sites in 
σΑ- and aB-crystallin might indicate that the polypeptides are differently arranged 
within the aggregate. However, the susceptibility of the C-terminal regions towards 
various modifications might endorse the quaternary structure models in which all 
subunits are in equivalent positions and in which the outside surface of the crystallin 
aggregate consists of the C-terminal domain regions, viz. the micelle structure model 
(Augusteyn and Koretz, 1987) or the rhombic dodecahedron model (Wistow et af.. 
1993). 
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Table 1 : Modifications of σΑ-crystallin 
Amino acid Modification Reference 
Metí 
His7 
ТгрЭ 
Lys11 
Aspi 51 
Seri 68 
Seri 69 
Seri 72 
in vivo N-terminal acetylation 
in vivo oxidation 
photooxidation and crosslinkino 
in vitro truncation 
photooxidation 
in vitro 'glycation' 
in vitro carbamylation 
Arg 12 
His 97 
Asn101 
Tyr109 
Seri 22 
in vitro truncation 
photooxidation 
in vivo truncation 
in vivo deamidation, racemization 
and isomerization 
in vitro iodination 
in vivo phosphorylation 
in vivo truncation 
in vivo racemization 
His154 
Glu156 
Arg 157 
Prol 60 
Vali 61 
Seri 62 
Arg 163 
Lys166 
photooxidation 
in vitro truncation 
in vitro truncation 
in vitro truncation 
in vitro truncation 
in vitro truncation 
in vivo glycosylation 
in vitro truncation 
in vitro 'glycation' 
in vitro acetylation 
photooxidation and crosslinking 
in vivo truncation 
in vitro truncation 
in vivo truncation 
in vivo truncation 
Driessen et al., 1985 
Takemoto ere/., 1992 
Dillon et al., 1993 
Siezen and Hoenders, 1979 
Dillon et al., 1987 
McDermott et al., 1991 
Ortwerth et al., 1992 
Qin et al., 1992 
Siezen and Hoenders, 1979 
McDermott et al., 1991 
van Kleef étal., 1976 
Voorter et al., 1988 
Hendriks et al., 1990 
Voorter et al., 1986 
Chiesa et al., 1987a 
van Kleef et al., 1974 
Groenen et al., 1990 
Fujii et al., 1991 
McDermott et al., 1991 
Siezen and Hoenders, 1979 
Siezen and Hoenders, 1979 
Siezen and Hoenders, 1979 
Siezen and Hoenders, 1979 
Yoshida et al., 1986 
Roquemore et al., 1992 
Siezen and Hoenders, 1979 
Yoshida et al., 1986 
Ortwerth et al., 1992 
Hasan et al., 1993 
Dillon et al., 1993 
de Jong et al., 1974 
Siezen and Hoenders, 1979 
de Jong et al., 1974 
Emmons and Takemoto, 1992 
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Table 2: Modifications of σΒ-crystallin 
Amino acid Modification Reference 
Metí 
Trp9 
Seri 9 
Ser45 
Ser59 
Met6B 
Asn146 
Arg 157 
Arg 163 
Lys 166 
Alai 68 
Thr170 
Lys 174 
Lys175 
in vivo N-terminal acetylation 
photooxidation 
in vivo phosphorylation 
photooxidation 
in vivo deamidation 
in vitro truncation 
in vitro truncation 
in vitro 'glycation' 
in vitro truncation 
in vivo truncation 
in vitro truncation 
in vitro truncation 
in vitro 'glycation' 
in vitro 'glycation' 
transglutaminase substrate site 
Dnessen et al., 1985 
Dillon et al., 1987 
McDermott et al., 1991 
Chiesa et al., 1987b 
Voorteref al., 1989 
Smith et al., 1992 
Dillon et al., 1993 
Groenen et al., 1993a 
Siezen and Hoenders, 1979 
Yoshida et al., 1986 
Ortwerth et al., 1992 
Siezen and Hoenders, 1979 
van Kleef et al., 1976 
Siezen and Hoenders, 1979 
Yoshida et al.. 1986 
Siezen and Hoenders, 1979 
Ortwerth et al., 1992 
Ortwerth et al., 1992 
Groenen et al., 1992 
Tables 1 and 2: Modifications of σΑ- and σΒ-crystallin. Modifications are described for human 
crA-crystallin dn vivo oxidation of Metí and in vivo truncation at Seri 72), for rat σΑ-crystallin 
[in vitro lodmation of ТугІОЭ) and for bovine σΑ- and σΒ-crystallins (all other modifications) In 
vitro acetylation, carbamylation and 'glycation' leads to modification of all lysine residues, 
however only the most reactive residues are indicated. This is also the case for in vitro 
lodmation of tyrosine residues. 
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In the ß-crystallins various posttranslational modifications, including 
phosphorylation (Kleiman et al., 1988), degradation (Vermorken et al., 1977; David et 
al, 1992;1993) and transglutaminase-catalyzed crosslinking (Berbers et al., 1984; 
Mulders et al., 1987; Groenen et al., 1993 b,c) have been described. These 
modification sites are all within the nonconserved regions at the N- or С-terminus of the 
ß-crystallin polypeptides. These regions extend beyond the more highly conserved 
globular domains and their function remains unknown. It has been postulated that they 
may contain interaction sites that stabilize oligomerization of the Q-crystallin 
polypeptides (Bateman and Slingsby, 1992). However, crystallographic analysis 
indicates that ßB2-extensions in the BB2-dimers do not occupy fixed positions (Lapatto 
et al., 1991). This suggests that the extensions only make a limited contribution to 
dimer formation and that they may have a random structure. This random structure 
may be the property that targets the N- and С-terminal extensions for posttranslational 
modification. 
The main difference between the B- and the κ-crystallins, is the absence of N-
and C-terminal extensions in κ-crystallin. This probably contributes to the fact that y-
crystallins hardly undergo posttranslational modifications. The only in vivo 
posttranslational modifications that have been established in κ-crystallins are glycation 
(Chiou et al., 1981; van Boekel et al., 1992) and peptide bond cleavage (Srivastava et 
al., 1992, 1993). In both human γΌ- and ys-crystallin, peptide bond cleavage occurred 
in the peptide that connects the two globular domains. 
The studies described afore provide evidence that the lens crystallins, and 
particularly σ-crystallin, undergo a multitude of posttranslational modifications. Several 
of these modifications probably affect the structural integrity of the eye lens proteins 
with respect to lens transparency. This hypothesis was investigated by Thomson and 
coworkers (1985). They isolated unmodified σΑ- and σβ-polypeptides from σ-crystallin 
prepared from human cataractous lenses and then reconstituted the multimene protein. 
It was found that the original σ-crystallin from cataracts had an abnormal circular 
dichroism spectrum indicating an altered tertiary structure, whereas the spectrum for 
the reconstructed σ-crystallin was similar to foetal σ-crystallin. Moreover, Ifeanye and 
Takemoto (1990) showed that human σ-crystallin from cataracts had a decreased 
ability to bind to lens membranes. Both observations support the idea that 
posttranslational modification of lens proteins causes the protein unfolding and 
aggregation seen in human cataracts. 
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SITE-SPECIFIC RACEMIZATION IN AGING σΑ-CRYSTALLIN 
ABSTRACT 
Of all aspartyl residues in bovine σΑ-crystallin, only Asp-151 exhibits 
pronounced racemization. Asp-151 is also one of the sites where peptide bond 
cleavage occurs in in vivo aging σΑ-crystallin. This aspartyl residue is followed by an 
alanyl residue and resides in a flexible carboxyl terminal extension of σ-crystallìn. Both 
in vivo and in vitro racemization studies indicate that the pronounced and site-specific 
racemization of Asp-151 proceeds via formation of a succinimide intermediate. The in 
vivo racemization of aspartyl residues in σΑ-crystallin is discussed with regard to the 
proposed tertiary structure of σ-crystallin. 
INTRODUCTION 
The vertebrate eye lens constitutes, due to the longevity of its proteins, a very 
suitable model for studying posttranslational modifications and aging of proteins [1-5]. 
The age-related modifications have most thoroughly been studied in σ-crystallin [4,6,7], 
which is a major structural protein in almost all vertebrate eye lenses. This protein is 
composed of 2 types of polypeptide chains, σΑ and σΒ, which are 173 and 175 
residues in length, respectively, and show approximately 55% sequence identity [7,8]. 
We recently reported the deamidation and peptide bond cleavage at Asn-101 in 
bovine σΑ-crystallin [9]. In this study, we showed that both the in vivo deamidation 
and cleavage occur via formation of a succinimide ring, which upon hydrolysis yields a 
mixture of normal and B-isomerized aspartyl residues and C-terminal asparagine and 
aspartic acid amide. These processes are accompanied by significant racemization. 
Age-related racemization of L-aspartic acid, leading to the enantiomeric D-
aspartic acid residue, has been observed in several long-lived proteins, like those in 
tooth enamel, dentine [10,11], proteins in the white matter of brain [12] and eye lens 
proteins [13-16]. However, in these studies the D/L ratio of total proteins or protein 
fractions was determined, with no correlation to individual aspartyl residues. Increasing 
evidence has been provided that specific aspartyl and asparaginyl residues in peptides 
and proteins can undergo extremely rapid racemization via formation of a five-
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membered succinimide intermediate [17], in contrast with the much slower 
racemization of aspartic acid, which proceeds by simple acid-base chemistry at the a-
carbon [18]. Therefore, it is of particular interest to examine the racemization of 
individual aspartyl residues. To gain insight in the in vivo extent of racemization of 
individual aspartyl residues in aging proteins, we determined the D/L ratio of all aspartic 
acid residues in bovine σΑ-crystallin of different ages. Only a single aspartyl residue 
exhibits pronounced racemization. This aspartyl residue is also one of the sites, where 
peptide bond cleavage occurs in in vivo aging σΑ-crystallin. 
MATERIALS AND METHODS 
Bovine eye lenses, approximately 6 months and 5 to 8 years old, were obtained 
through the Central Animal Facilities of the University of Nijmegen, School of Medicine. 
Isolation and digestion of σΑ-crystallin 
The lenses were dissected into cortex and nucleus, and subsequently 
homogenized in a buffered solution containing 50 mM Tris, 50 mM NaCI and 1 m M 
EDTA, pH 7.4. Water-soluble (WS) and urea-soluble (US) protein fractions were 
prepared by the extraction procedure as described by Bloemendal [8]. σΑ-Crystallin 
from calf lens cortex (6 months) and bovine lens nucleus (5 to 8 years) was isolated by 
gel permeation chromatography on Ultrogel AcA34 (Pharmacia LKB Biotechnology Inc.), 
followed by ion exchange chromatography on DEAE-cellulose (Whatman DE-52) or by 
carboxymethylceilulose (Whatman CM-52) as described previously [19]. 
The σΑ-subunits were digested with trypsin and the resulting peptides were 
preparatively isolated by high voltage paper electrophoresis at pH 6.5 followed by 
descending chromatography [20]. After visualization with fluorescamine, peptides were 
identified by amino acid analysis. Two of the peptides, T13 and T18, could not be 
separated in this way, and were further analysed either by high voltage re-
electrophoresis at pH 3.5 or by thermolytic digestion at 50°C in 0.1 M NH4HC03, pH 
8.9 using a peptide concentration of 0.5 nmol/μΙ. The resulting thermolytic peptides 
were separated by high voltage electrophoresis at pH 6.5 [20]. 
In vitro racemization of σΑ-crystallin 
Purified σΑ-crystallin from the water-soluble fraction of calf lens cortex (6 
months) was incubated under vacuum in a concentration of 10 nmol/150//l in 0.1 M 
sodium phosphate buffer, pH 7.4 at 70°C [17]. Incubations were terminated at 
different time intervals by short dialysis and subsequent lyophilization. D/L-Asp ratios 
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were determined after isolation of Asp-containing peptides as described. 
Analysis of aspartic acid enantiomers 
The D/L-Asp ratios of peptides were determined by high performance liquid 
chromatography after acid hydrolysis for 6 hours at 1 1 0 ° C and after conversion of D/L 
enantiomers into diastereomers as described [21]. No corrections for background 
racemization were made, because the racemization rate of individual aspartyl residues 
during acid hydrolysis strongly depends on their local environment [22]. 
RESULTS AND DISCUSSION 
D/L Aspartic acid ratios of all individual aspartyl residues of water-soluble and 
urea-soluble σΑ-crystallin were determined (Table 1). Among the 14 aspartyl residues 
of the σΑ-subunit of σ-crystallin, only a single one, at position 1 5 1 , exhibits pronounced 
racemization. As illustrated in Fig. 1., the enantiomeric ratio of Aspi 51 increases from 
0.040 in water-soluble σ-crystallin from calf lens cortex to 0.327 and even to 0 . 4 9 3 in 
water-soluble and urea-soluble σΑ-crystallin from bovine lens nucleus, respectively. 
Since racemization is an age-dependent process, the increase in racemization from 
water-soluble to urea-soluble σ-crystallin provides evidence that σ-crystallin becomes 
progressively less water-soluble with increasing age, as previously indicated by others 
[23]. The D/L ratios of all other aspartyl residues range from 0 . 0 1 0 to 0.021 in young 
water-soluble σΑ-crystallin and increases to 0.025 to 0 . 0 8 0 in urea-soluble σΑ-
crystallin of old bovine nucleus. This slow increase in racemization can be attributed to 
simple acid-base chemistry at the σ-carbon, whereas the pronounced and 
Fig. 1. Diastereomeric HPLC separation of T18 
hydrolysate, isolated from water-soluble fractions of 
calf lens cortex (A) and bovine lens nucleus, 5 years 
(B), and from urea-soluble fraction of bovine lens 
nucleus, 5-8 years 1С). Separation was performed on 
a reversed-phase HPLC column (C18, Chrompack). 
Diastereomeric dérivâtes were eluted isocratically 
with 50 mM sodium acetate pH 5.7, 3.2% 
methanol. 
1 = diastereomeric derivative of D-aspartic acid. 
"m™ 2 = diastereomeric derivative of L-aspartic acid. 
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site-specific racemization of Aspi 51 will be the result of formation of a succinimide 
intermediate. This is strongly confirmed by in vitro racemization studies. Table 2 shows 
that only Aspi 51 racemízes upon incubation of σΑ-crystallin, under conditions that 
favor succinimide formation. The D/L ratios of other aspartyl residues hardly increase 
upon in vitro incubation. 
Studies with model peptides have shown that succinimide formation is highly 
dependent on the local conformation and the neighboring residues. oA-Crystallin 
contains Asp-Ser and Asp-Gly sequences (T6 and Τ 17b peptides) that have the chemi­
cal susceptibility of ¡mide ring formation [17,24]. However, in σΑ-crystallin, these 
aspartyl residues have low D/L ratios. Our results thus show that it is difficult to predict 
the rate of succinimide formation from sequence data alone. The local conformation of 
aspartyl or asparaginyl residues in peptides and proteins may be of much more 
importance in determining the rate of succinimide formation [22,25]. 
Because of the strong conformational constraints, succinimide-linked reactions 
occur most prevalently in partially denaturated or conformationally flexible regions of 
proteins [22]. The extreme and site-specific racemization of Aspi 51 in σΑ-crystallin 
suggests that this region is located in a conformationally flexible region of the protein. 
This is indeed supported by earlier work, which provided evidence that Aspi 51 resides 
in the flexible surface-exposed carboxyl-terminal arm of σ-crystallin [19,26,27]. All 
other aspartyl residues reside in specific σ-crystallin domain structures and may be 
involved in formation and stabilization of the tertiary structure of globular σ-crystallin. 
Asp2, Asp35, Asp69 and Aspi05 are considered to be of potential structural 
importance, as they are extremely well conserved among σ-crystallins of different 
animals [27]. These σ-crystallin domain structures may be extremely stable and 
therefore do not permit succinimide formation at aspartyl residues. 
Interestingly, Aspi 51 is also one of the sites, in addition to Asn101, where 
peptide bond cleavage occurs in aging σΑ-crystallin [28]. It is therefore tempting to 
speculate that the cleavage between Aspi51 and Alai52 might proceed non-
Table 2: D/L ratio of aspartyl residues of ffA-crystallin, after in vitro incubation in 0.1 M sodium 
phosphate buffer, pH 7.4 at 70eC. The D/L ratio of T18, containing the in vivo fast racemizing 
Asp-151, and of several control peptides was determined. Values are the mean of two 
independent incubations, whereas D/L ratios were measured in triplicate. 
Tryptic peptide« Incubation t i » e (day«) D/L-Aap r a t i o 
T18 0 0.040 
6 0.079 
19 0.158 
T7-8 19 0.029 
T10 19 0.040 
T i l 19 0.044 
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enzymatically via intramolecular ring formation, which has already been demonstrated 
in vivo at Asn101 in σΑ-crystallin [9] and in vitro at a specific aspartyl residue of 
calmodulin [ 2 9 ] . The peptide bond cleavage at Asn101 in σΑ-crystallin was shown to 
proceed via formation of a C-terminal succinimide ring and was accompanied by 
enhanced racemization. Whether the in vivo cleavage at A s p i 51 also occurs by 
intramolecular cyclization, via a succinic anhydride intermediate, is still not clear. 
Although the D/L ratio of A s p i 51 in the in vivo truncated cA 1 , 6 1 -chain is low, an 
enzymatic process is not very plausible, because no enzyme is known to bring about 
such cleavage. Further experiments are needed t o elucidate the cleavage mechanism at 
this aspartyl residue. 
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AGE-DEPENDENT DEAMIDATION OF oB-CRYSTALLIN 
ABSTRACT 
Bovine and human σΒ-crystallin undergo deamidation upon aging in the lens. In 
bovine σΒ-crystallin, the specific site of deamidation has been identified by peptide 
mapping after tryptic digestion. Asn146 was found to be subject to deamidation, 
whereas the only other asparagine residue, at position 78, is not affected. Asn146 is 
flanked at the carboxylic side by a glycyl residue. Yet, the rate of in vivo deamidation is 
low. In vitro studies reveal that the deamidation is accompanied by significant 
racemization, indicating that the deamidation proceeds via formation of a succinimide 
intermediate. 
INTRODUCTION 
One of the most abundant structural proteins in the eye lens is σ-crystallin. This 
protein occurs as large water-soluble aggregates (up to 10° Da) and is composed of 
two types of related subunits, σΑ- end σΒ-crystallin. The absence of protein turnover in 
the inner part of the lens makes it necessary that the crystalline are extremely stable 
and long-living proteins [1). σ-Crystallin is therefore an excellent model for the study of 
in vivo aging of proteins. σ-Crystallins also occur in several cell types and organs 
outside the lens [2,3] and increased levels of σΒ-crystallin have been observed in 
several neurological disorders [4,5] and in cell lines under stress conditions [6]. There is 
a striking sequence homology between σ-crystallin and the small heat shock proteins 
[7,8]. Recent studies demonstrate that they also have functional similarities [6] and 
that both σ-crystallin and the small heat shock proteins can function as molecular 
chaperones [9,10,11]. 
From this functional point of view it is relevant to increase the understanding of 
the stability and in vivo modifications of σ-crystallin. It has been shown that both σΑ-
and σΒ-crystallin undergo various posttranslational modifications, both enzymatic and 
nonenzymatic (1,12,13]. Deamidation is one of the major nonenzymatic modifications 
in aging proteins [14] and constitutes indeed a problem of considerable concern in 
protein engineering [15]. Deamidation was proposed at an early stage to contribute to 
53 
the observed charge heterogeneity of the a-crystallin chains [16]. Only more recently 
could the specific sites of deamidation in chicken and bovine σΑ-crystallin [17,18] be 
established. In the present study we describe the age-dependent site-specific 
deamidation of bovine oB-crystallin at Asn146. 
MATERIALS AND METHODS 
Bovine eye lenses of different ages were obtained through the Central Animal 
Facilities of the University of Nijmegen, School of Medicine. Human lenses were 
provided by Dr. G. Vrensen (the Netherlands Ophthalmic Research Institute, 
Amsterdam) and by Dr. M. Hogeweg (Academic Hospital, Leiden). 
σ-Crystallin from calf lens cortex (6-months-old), bovine lens nucleus (5- years-
old) and human lenses (75- to 85-years-old) was isolated from the water-soluble 
fraction by gel permeation chromatography on Ultrogel AcA-34 (Pharmacia LKB). 
Bovine σΒ-crystallin was purified by ion exchange chromatography on DEAE-cellulose 
(Whatman DE-52) and was digested with trypsin ( 1 % , w/w). The resulting peptides 
were isolated by high voltage paper electrophoresis at pH 6.5 followed by descending 
chromatography [19]. After visualization with fluorescamine, peptides were identified 
by amino acid analysis. The T16 peptide was further analyzed by thermolytic digestion 
(2%, w/w) at 50°C in 0.1 M NH4HC03, pH 8.9, using a peptide concentration of 0.5 
nmol/μΙ. The resulting thermolytic peptides were separated again by high voltage 
electrophoresis at pH 6.5. 
In vitro deamidation of ΰ-crystallin and purified oB-subunits from 6 months-old 
calves was performed under vacuum in 0.1 M sodium phosphate buffer, pH 7.4, at 
70°C, using a protein concentration of 10 nmol/150^1 [20]. Incubations were 
terminated at different time intervals by short dialysis and subsequent lyophilization. 
D/L Aspartic acid ratio's (or %D-Asp) were determined after isolation of Asp-containing 
peptides as described [21,22]. 
Alkaline urea gel electrophoresis was carried out at pH 8.5 [19]. Two-
dimensional gel electrophoresis was performed according to O'Farrell [23]. 
RESULTS 
Analysis by two-dimensional gel electrophoresis of σ-crystallin isolated from the 
water-soluble fraction of 75- to 85-years-old human lenses reveals a characteristic 
54 
pattern, composed of σΑ- and σΒ-crystallin and several posttranslational modification 
products (Fig. 1). It is known from earlier studies that bovine σΑ- and σΒ-crystallin both 
undergo phosphorylation [24-26] and that σΑ-crystallin in addition undergoes site-
specific deamidation of A s n 1 0 1 , which is accompanied by isomerization, racemization 
and peptide bond cleavage [ 1 8 ] . Also in human σΑ-crystallin conspicuous deamidation 
of Asn101 has been observed [ 2 7 ] . No evidence has been provided yet for the 
occurrence of deamidation in σΒ-crystallin, although Kramps et al. [27] isolated from 
human, but not from bovine o-crystallin, an σΒ-subunit that they suspected t o be 
deamidated. Indeed, the two-dimensional gel pattern of human σ-crystallin shows a 
spot wi th one more negative charge than σΒ-crystallin, responding positively t o an 
antiserum specific for σΒ-crystallin (data not shown), indicative for a deamidated σΒ-
crystallin product. There are only 4 amino acid differences between bovine and human 
σΒ-crystallin [ 2 8 , 2 9 ] , not involving the sequences surrounding the only t w o asparaginyl 
residues. For this reason and because bovine lenses were more easy to obtain, the in 
vitro and in vivo deamidation of σΒ-crystallin was studied using bovine σ-crystallin. 
Bovine σΒ-crystalllin undergoes a single charge difference upon incubation in 
100 mM phosphate buffer pH 7.4 at 7 0 ° C , conditions that favor succinimide formation 
<-) (+) 
Fig. 1. Coomassie brilliant blue-stained two-
dimensional gel pattern of σ-crystallin, 
isolated from the water-soluble fraction of 
aB otEPaEP « B p p 75- to 85-years-old human lenses. The 
аАа/1?«Ар superscripts * p and " indicate the 1 у f presumed deamidated, mono- and di-phosporylated σ-crystallin subunits. 
(.-) Fig. 2. Alkaline urea gel electrophoresis 
tB— Ц^Ь JÊÊL ^ ^ ^
 A л pattern showing deamidation of oB-
crvstallin. (1) σ-crvstallin isolated from the 
«A— 
^ Л 
y y
« В — %ШШШ Ê I Ê Ê Ê water-soluble f ract ion of calf lens cortex 
xBD— (35 /yg), (2) σΒ-crystallin isolated f r o m calf 
lens cortex (5 μα,), (3) σΒ-crystall in, in vitro 
deamidated for 7 hr at 7 0 ° С under vacuum 
(12.5 μα,), (4) σ-crystallin isolated f r o m the 
water-soluble f ract ion of 5-years-old bovine 
lens nuclei (75 μα), (5) o B ^ c r y s t a l l i n , 
isolated f r o m 5-years-old bovine lens nuclei 
(20 μα)- The in vitro and in vivo oB d -product 
is located between σΒ-crystallin and the 
m o n o p h o s p h o r y l a t e d o B B - c r y s t a l l i n , 
demonstrating a single additional negative 
charge in σΒ"- relative to σΒ-crystallin. 
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[20,30,31] (Fig. 2, lanes 2,3). This presumed deamidation process of oB-crystallin 
proceeds very quickly, the VA value is 8 hours. To find out if this charge difference is 
indeed due to the deamidation of an asparaginyl residue, tryptic peptide mapping of the 
native and modified oB-crystallin was performed. The tryptic peptide maps of the two 
chains were identical apart from a change in mobility of a single peptide (Fig. 3). Upon 
analysis of the amino acid composition, this peptide was identified as T 1 6 , comprising 
residues 1 2 4 - 1 4 9 of the σΒ-chaìn [28]. This peptide contains an Asn residue at position 
146 that is flanked by a glycyl residue. In addition to Asn 146 there are in this peptide 
three Asp residues (positions 127, 129 and 140) of which Aspi 40 is also followed by 
Gly. It is known that Asn-Gly sequences are particularly prone to deamidation via 
succinimide formation, which leads to isomerization and racemization as well [20]. 
Similarly, Asp-Gly sequences can easily form succinimide rings, again leading to 
enhanced isomerization and racemization. To check whether racemization occurs 
concomitantly during deamidation of oB-crystallin, the percentage of D-Asp in the 
tryptic peptide T16 and its thermolytic fragments was determined. Table 1 shows that 
the level of racemization of T16 increases from 2.2% to 17 .3% during 96 hours of 
incubation. This increase is largely accounted for by the strong racemization of 
deamidated Asm 46 (T16Th4d) and Aspi 40 (T16Th3). The level of D-Asp of other 
aspartyl residues hardly increases upon in vitro incubation. 
To assess whether deamidation of oß-crystallin also occurs in vivo, σ-crystallin 
was isolated from 5-years-old bovine lens nuclei. This fraction contains a band that 
corresponds in electrophoretic mobility with the in vitro deamidated σΒ-product (Fig. 2, 
lane 4). The amount of this product relative to the unmodified oB-chain in 5-years-old a-
ELECTROPHORESIS 
Fig. 3. Peptide map of tryptic digest of bovine οβ-crystallin. The arrow indicates the 
displacement of T16 (dashed) in the deamidated oB-chain. This displacement was found both 
upon in vitro deamidation (incubation time 24 hr) and in the in vivo deamidated oB-crystallin 
isolated from 5-years-old bovine lens nuclei. 
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Table 1: Racemization of aspartyl residues of аВ-crystallin after in vitro incubation in 0.1 M 
sodium phosphate buffer, pH 7.4 at 70°С Values are the mean of two independent 
incubations; percentages of D-Asp were measured in triplicate. 
Peptide! aa indicated % D-Aap 
t=0 
% D-Aap 
t=96 hr 
T16 
T16 
Т16ТЫ 
T16Th3 
T16Th4 
T16Th4 
T4 
T6 
T12 
: Ala-Aep , 7 7-Val-Aap1 2 ,-Pro 
ser-Asp'*-Gly 
Val-Asn l 4 6-Gly 
: Aan14«-· Aap'46 
: Ala-Aap l 2 7-Val-Aip l 2 9-Pro 
: Ser-Aep'*-Gly 
: Val-Asn1 4 6-Gly 
: Aan'«-» Aap146 
: I l e-Aap n -Thr 
: Lys-Aap^-Arg 
: Gln-Aspl09-Glu 
2.2 % 
17.3 % 
1.5 % 5.2 % 
2.3 % 24.2 % 
2.3 % 
28.7 % 
2.9 % 6.7 % 
2.0 % 4.1 % 
1.8 % 2.7 % 
Peptides T4, T6 and T12 are included for comparison 
crystallin is estimated at about 20%, whereas in young σ-crystallin this product is 
absent (Fig. 2, lane 1). These data clearly point out that the deamidation of σΒ-
crystallin is an age-dependent process. The supposed deamidated oB-product was 
purified by means of anion-exchange chromatography (Fig. 2, lane 5). Tryptic peptide 
mapping revealed again the displacement of T I 6, demonstrating that Asm 46 of bovine 
oB-crystallin deamidates in vivo as well. The identification of Asn146 as site of 
deamidation is supported by the finding that chicken σΒ-crystallin, which lacks the 
corresponding Asn residue, is not deamidated at all ¡n 10-years-old lenses (see Fig.3 in 
117]). 
DISCUSSION 
The number of well-characterized in vivo deamidation sites in cellular proteins is 
still quite limited [32,33]. In only a few proteins, particularly the long-living lens 
crystallins, deamidation has been correlated with aging 134]. Besides the site-specific, 
age-dependent deamidation in chicken -, bovine - and human σΑ-crystallin [17,18,27], 
we now provide evidence that also bovine σΒ-crystallin undergoes site-specific 
deamidation at Asn146, both during in vitro incubation and upon in vivo aging of this 
protein in the lens. The deamidated σΒ-crystallin reaches a level of at least 20% in 5-
years-old bovine lens nuclei, whereas it is not detectable in 6-month-old calf lens 
cortex. High levels of deamidated σΒ-crystallin can also be observed in 75- to 85-years-
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old human lenses (Fig. 1), while this modification product is not detectable in fetal 
human lenses (see Fig. 1В in [35]). 
Because σΒ-crystallin rapidly deamidates in vitro under conditions that favor 
succinimide formation and because of the pronounced racemization that was found to 
accompany the site-specific deamidation, we assume that the deamidation of σΒ-
crystallin under physiological conditions in the lens also proceeds through an imide 
intermediate. It is known from previous studies that the rate of succinimide-mediated 
reactions is strongly influenced by the surrounding residues [20,36,37]. Amino acids at 
the amino side of Asn or Asp have little or no effect, whereas amino acids at the 
carboxylic side of Asn or Asp affect the imide ring formation significantly. In general, 
the rate of succinimide-linked reactions is decreased as the size and steric bulk of the 
carboxylic flanking residue increases. Hence, Asn-Gly sequences easily undergo 
deamidation. Here we demonstrate that deamidation of bovine σΒ-crystallin actually 
occurs at Asn146-Gly147. However, the rate of in vivo deamidation at Asn146 is low, 
indicating conformational contraints on the deamidation process [32]. The only other 
asparagine residue present in bovine (and human) σΒ-crystallin (Asn78) is flanked by a 
bulky leucine residue and does not deamidate. 
Imide ring formation at aspartic acid residues, which recently has been 
demonstrated to occur in vivo [38], leads to their isomerization and racemization. In 
previous studies, it has been inferred that this process takes place in bovine orA-
crystallin of which a single aspartyl residue exhibits pronounced age-dependent 
racemization [22,39]. A similar modification has now been found in σΒ-crystallin. 
Among the 3 aspartyl residues in T16, only Aspi40 becomes strongly racemized upon 
incubation of σΒ-crystallin under conditions that favor succinimide formation. Like 
Asn 146, this Aspi40 is flanked by a glycine residue at the carboxylic side. 
It is not clear whether deamidation of σΒ-crystallin has any influence on its 
functioning as a lens structural protein. Outside the lens, however, the role of σΒ-
crystallin as a stress protein will probably not be affected by this modification because 
of the low deamidation rate at 37°C. 
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THE CARBOXYL-TERMINAL LYSINE OF oB-CRYSTALLIN IS AN AMINE-DONOR 
SUBSTRATE FOR TISSUE TRANSGLUTAMINASE 
ABSTRACT 
A hexapeptide, corresponding with the sequence around the glutamine in ßA3-
crystallin that functions as amine-acceptor for transglutaminase, was synthesized. This 
peptide was biotinylated and used as a probe to identify amine-donor substrates for 
transglutaminase among lens proteins. It was found that CaJ+-activated 
transglutaminase linked this peptide not only to several ß-crystallms but, unexpectedly, 
also to σΒ-crystallin. The C-terminal lysine residue of oB-crystallin could be identified as 
the site of linkage. This strengthens the notion that, at least in crystalline, all 
transglutaminase substrate residues are located in terminal extensions of the 
polypeptides. It was shown that in lens homogenate, σΒ-crystallin can be covalently 
crosslinked to ß-crystallins by transglutaminase. The transglutaminase-mediated 
crosslinking of σΒ-crystallin may have implications for its involvement in normal and 
pathological processes in lens and other tissues. 
INTRODUCTION 
σ-Crystallin is a major structural protein of the vertebrate eye lens [1,2] It 
occurs as large water-soluble aggregates (molecular mass around 800 kDa), composed 
of two types of related subunits, σΑ and σΒ. The σΒ chain has recently been found in a 
variety of tissues outside the lens, notably in heart, striated muscle and kidney [3-6]. 
Increased levels of σΒ have been observed in various neurological disorders [4,7-9] and 
other degenerative diseases [10]. σ-Crystallin is structurally related with the ubiquitous 
small (15-30 kDa) heat shock proteins [11,12], and σΒ-crystallin behaves indeed in 
several respects like those stress proteins [13]. 
The functions of oB-crystallin under normal and pathological conditions are fully 
unknown Establishing the biological properties of this protein is therefore of major 
interest. Modifying and extending earlier approaches [14-16], we here demonstrate that 
σΒ-crystallin, but not σΑ, is an amine-donor substrate for tissue transglutaminase. This 
enzyme occurs in most cell types and catalyzes the formation of f-(K-glutamyl)-lysine 
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isopeptide crosslinks between polypeptides, and the conjugation of amines to protein-
bound glutammes [17,18]. The biological function of tissue transglutaminase is 
uncertain, but it has been implicated in controlled cell death [19], tumor progression 
[20], stimulated secretion [21] and receptor-mediated endocytosis [22]. We have found 
that σΒ-crystallin can be covalently crosslinked to other proteins by transglutaminase, 
and identified the C-terminal lysine residue of σΒ as the amine-donor substrate for the 
enzyme. 
MATERIALS AND METHODS 
Preparation of the biotinylated amine-acceptor probe 
An amine-acceptor peptide, H-Thr-Val Gln-Gln-Glu-Leu-OH, was synthesized on 
an Advanced Chem Tech peptide synthesizer, using the solid-phase method. The 
amine-acceptor peptide (10 mg) was biotinylated by incubation with 4 mg NHS-LC-
biotine (Pierce) for 2h at room temperature in 1 ml 0 1 M NH4HC03, pH 8.0 The 
reaction was stopped by addition of 50 μ\ 1 M Tris-HCI, pH 7.5, and the peptide was 
lyophilized and dissolved in water at a concentration of 100 mM. 
Identification of lysine substrates [modified after 14-16] 
Calf lens homogenate (5 mg protein) or purified crystalline (1 mg protein) were 
preincubated at 37°C for 15 mm with 0 01 U guinea-pig liver transglutaminase (Sigma) 
and the biotinylated amine-acceptor peptide (2 mM final concentration) in 50 mM Tns-
HCI pH 7 5, 100 mM NaCI, 20% glycerol, 1 mM phenylmethylsulfonyl fluoride (Merck) 
and 2 mM leupeptin (Sigma), in a total volume of 140 μ\ Reactions were initiated by 
the addition of CaCI2 (8 7 mM). After 2h of incubation, the reaction was stopped by 
the addition of EDTA (20 mM final concentration) Samples were analyzed by SDS-
PAGE [23], followed by staining with Coomassie brilliant blue or by streptavidin blot 
analysis 
Transglutaminase-mediated crosslinking of crystalline 
Incubations were performed as above, but without addition of the biotinylated 
amine-acceptor probe. Samples were analyzed by SDS-PAGE [23], followed by staining 
with Coomassie brilliant blue or by immunoblot analysis. 
Streptavidin blot analysis 
Nitrocellulose blots were blocked with 2% BSA, 0 1% Tnton-X100 in PBS for 
30 mm at room temperature. Blots were then incubated for 30-60 mm in PBS, 
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containing streptavidin-horseradish peroxidase conjugate (Zymed, dilution 1:1000) and 
0 . 1 % BSA, and washed three times for 15 mm per wash in PBS, containing 0 . 1 % BSA 
and 0.05% Tween-20. Bands were visualized using 4-chloro-1-naphtol as substrate. 
After staining blots were rinsed with distilled water and air-dried. 
Miscellaneous methods 
Homogenates were prepared from calf lens cortex in 50 mM Tris-HCI, pH 7.5, 
100 mM NaCI at a final protein concentration of 50 mg/ml. a-, BHigh-, ßLow- and y-
crystallms were isolated from calf lens cortex, dogfish and chicken lens water-soluble 
fractions by gel permeation chromatography over Ultrogel AcA34 (Pharmacia LKB). σΑ-
and oB-crystallin were separated by ion-exchange chromatography on DEAE-cellulose 
(Whatman DE-52) [24]. Digestion of oB-crystallm with carboxypeptidase В (Merck) was 
performed as described by Siezen et al. [25]. Alkaline urea gel electrophoresis was 
carried out at pH 8 5 [24]. Immunoblot analysis was performed according to Mulders et 
al [26]. Both the polyclonal antiserum against bovine oB-crystalhn and the second 
antibody (SwaRPO.Dakopatts) were used at a 1:200 dilution. 
RESULTS AND DISCUSSION 
Amine-donor substrates for transglutaminase can be identified with the use of 
synthetic amine-acceptor peptides, which inhibit the normal transglutaminase-mediated 
crosslmking of polypeptides by blocking the lysine donors [14-16]. The amine-acceptor 
peptide used, H-Thr-Val-Gln-Gln-Glu-Leu-OH, was patterned on the N-terminal extension 
of bovine ßA3-crystallin, which contains the major glutamine substrate site for 
transglutaminase among lens proteins [27]. Biotinylation of the amine-acceptor peptide 
was performed to facilitate the identification of lysine donor substrates by subsequent 
streptavidm blot analysis. 
Incubation of calf lens cortex homogenate in the presence of the biotinylated 
amine-acceptor probe, leads to the covalent attachment of this inhibitory peptide to 
specific lysine donor crystallins under the influence of transglutaminase and Ca2+ 
(Fig.1, lanes 2). Most of these peptide-decorated crystallins are, as expected [26,28], 
ß-crystallins (Fig. 1, lanes 4, 5). The intensity of the peptide-decorated BB1-crystallin on 
streptavidm blot is the strongest of all, indicating that BB1-crystallin has the highest 
affinity for the amine-acceptor probe. This confirms our earlier evidence, obtained by 
crosslmking and immunoblot analysis, that BB1-crystallin functions as an amine-donor 
substrate [26]. None of the κ-crystallins reacts with the amine-acceptor probe (Fig 1B, 
lane 6). However, it clearly and unexpectedly [28] appears that o-crystallin does also 
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Fig. 1. Transglutaminase-mediated binding of the biotinylated amine-acceptor probe to specific 
lens proteins. (A) A Coomassie-blue stained SDS-polyacrylamide gel and (B) the corresponding 
streptavidin blot. Calf lens proteins were incubated in the reaction mixture, containing CaJ* and 
the biotinylated amine-acceptor probe, without (lane 1) or with (lanes 2-6) the addition of 
guinea-pig liver transglutaminase. Samples are: lens homogenate (lanes 1,2; 4.3 μα in A and B), 
σ-crystallin (lane 3; 1.6 μα in A and 1.0 μα in B), BHigh-crystallin (lane 4; 2.2 μα in A and 1.0 
/yg in B), BLow-crystallin (lane 5; 1.3 μα in A and B) and κ-crystallin (lane 6; 1.3 μα in A and B). 
The band immediatly above the strong peptide-decorated BB1-band (B, lanes 2,4) probably is a 
double-decorated BB1-product. The higher molecular weight band that is clearly visible on the 
streptavidin blot (B, lanes 2,4; -•), but hardly on the Coomassie-blue stained gel, probably is a 
peptide-decorated crosslinking product, В indicates the position of BB2, BB3 and ВАЗ, which 
have similar molecular masses [27]. 
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Fig. 2. Transglutaminase-mediated crosslinking of аВ-crystallin. (A) Coomassie-blue stained 
pattern after SDS-PAGE; molecular weight markers (M in kDa) are indicated. (B) Immunoblot, 
probed with an antiserum specific for σΒ-crystallin. Incubations contained: lens homogenate 
(lanes 1,2; 5.5 μα in A and 11.0 μα in B), σ-crystallin alone (lanes 3,4; 3.5 μα) or with BHigh-
crystallin, 1:1, w/w (lanes 5,6; 9.0 μα)- Samples were incubated with EDTA (8.7 mM) and liver 
transglutaminase (controls; lanes 1,3,5) or with Ca2* (8.7 mM) and liver transglutaminase 
(lanes 2,4,6). The anti-σΒ serum reacts with the crosslinking product (CL), which can only be 
demonstrated if both a- and B-crystallin are present in the assay mixture (B, lanes 2,6). The σΒ-
band in lane 1,2 (B) appears very weak, due to an overloading effect. 
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react with the biotmyiated amine-acceptor probe (Fig.lB, lane 3). From the position of 
the labeled band on blot, and after Ponceau S staining of the blot, it becomes clear that 
Che biotmyiated peptide is bound to αβ-crystallin. 
Immunoblot analysis with an anti-σΒ specific antiserum after transglutaminase-
mediated crosslinking of lens proteins, in the absence of the amine-acceptor peptide, 
clearly shows that σΒ-crystallin becomes covalently linked to other proteins (Fig.2, 
lanes 2). The oB-containing crosslinking product can only be demonstrated in 
transglutaminase incubations of σ-crystallin together with ßHigh crystallin (Fig.2B, lanes 
2, 6) This is expected, since ß-crystallins are the only known glutamina substrates for 
transglutaminase among the eye lens crystallins [27-29]. The apparent molecular 
weight (about 55 kDa) of the crosslinking product indicates that it is a dimer of oß-
crystallin and one or the other of the amine-acceptor ß-crystalhns (ВАЗ. ßB2, UB3H27]. 
The specific glutamine amine-acceptor residues in the ß-crystallins, as well as 
the lysine substrate(s) in ßB1 -crystallin, are all located in the N-terminal extensions of 
these proteins [26,27] Bovine σΒ-crystallin differs i.a from σΑ-crystallin in having two 
lysine residues at its C-terminus [30] This C-terminal region is moreover supposed to 
form an extension from the proposed two-domain structure of the o-crystallin subunits 
[31] This suggested that one or both of these C-terminal lysines might be the amine-
donor substrate To corroborate this idea bovine oB-crystallin was digested with 
carboxypeptidase B, which releases the C-terminal Lys175 but not the penultimate 
Lys174, because it is preceded by a prolyl residue [251. The loss of a single positive 
charge, and thus the effectiveness of the digestion, is clearly demonstrated by alkaline 
urea gel electrophoresis (Fig ЗА) Subsequent reaction with the amine-acceptor probe, 
and analysis by SDS-PAGE and streptavidin blot shows that σΒ-crystallin no longer 
reacts with the probe upon removal of the C-terminal Lys175 (Fig.3 B,C, lanes 1, 2). 
Although less likely, it cannot be excluded that the penultimate lysine is the 
actual amine-donor, which needs the neighbouring lysine to serve as a substrate for 
transglutaminase We therefore performed this experiment also with oB-crystallin from 
dogfish and chicken, which like bovine oß-crystallin have a C-terminal lysine residue, 
but the penultimate residues are Gin and Arg, respectively (Fig 4). Both dogfish and 
chicken σΒ-crystallin react with the amine-acceptor probe and loose this property aftei 
digestion with carboxypeptidase В (Fig 3 В, C, lanes 3-6). This experiment thus 
convincingly demonstrates that the conserved C-terminal lysine residue functions as the 
sole amine-donor for tissue type transglutaminase in oB-crystallin. The fact that Lys175 
in oB-crystallin has been conserved as an amine-donor for transglutaminase for over 
4 108 years, while the preceeding residues have not, indicates that it may well serve an 
important function, not shared with oA. The variability of the preceeding residues 
demonstrates at the same time that the amine-donor lysine does not require a strictly 
determined adjacent consensus sequence, at least not in σΒ-crystallin However, the 
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Fig. 3. Identification of the amin e-donor lysine, through carboxy pept ¡dase В (CP-B) digestion of 
сгВ-crystallin. (A) Alkaline urea gel electrophoresis pattern of bovine σ-crystallin (18 //g) before 
(1) and after (2) CP-B digestion. The truncated oB-crystallin (arrow) is located between σΒ- and 
ffBp-crystallin (monophosphorylated) [32], demonstrating the loss of a single positive charge. 
CP-B does not effect σΑ-crystallin. (B) and (C) SDS gel electrophoresis pattern of calf o-
crystallin (lanes 1,2; 1.9 цд in A and 4.3 //g in B), dogfish σΒ-crystallin (lanes 3,4; 0.9 |/g in A 
and B) and chicken σ-crystallin, partially purified (lanes 5,6; 1.9 ¿/g in A and 3.3 цд in B), before 
(lanes 1,3,5) and after (lanes 2,4,6) digestion with CP-B. Note that the loss of a single lysine 
residue leads to a clearly detectable higher mobility in SDS-PAGE. All samples have been 
incubated with Ca2*-activated transglutaminase and the amine-acceptor probe. The Coomassie-
blue stained gel (B) and the corresponding streptavidin blot (C) show that the CP-B digestion of 
all three σΒ-crystallins is complete, and that the truncated crystalline do not react with the 
biotinylated probe. The weak biotinylated band above bovine oB-crystallin (C, lanes 1,2) is 
probably the peptide-decorated ßB1-crystallin. Molecular weight markers (M in kDa) are 
indicated. 
170 Fig. 4. Carboxy I-terminal sequences of 
аВ b o v i n e EEKPAVTAAPKK bovine [30], dogfish [33] and chicken σΒ-
_ . . . . „г,™,.,.«,,,,™». crystallin. The latter sequence is unpublished 
аВ d o g f i s h DEKPAVAGPQQK . ' , , . , . . , . , j » -, _ data of W.W. de J. and A. Zweers. The 
а в c h i c k e n EEKPAIAGSQRK amine-donor lysine is indicated in bold. 
presence of an adjacent proline apparently hampers reaction of Lys174 w i t h the amine-
acceptor probe. 
The identification of Lys175 as amine-donor in oB-crystallin strengthens the 
notion that, among crystallins, only glutamines or lysines in terminal extensions, 
protruding from the compactly folded domains, are accessible for transglutaminase. 
Whereas considerable information has been obtained concerning glutamines and lysines 
as substrates for transglutaminase in synthetic peptides [ 1 7 ] , little is known about 
amine-acceptor glutamine residues in native proteins, and even less about amine-donor 
lysines. Fast atom bombardment mass spectroscopy has recently been employed in the 
analysis of transglutaminase-mediated crosslinks in small monomeric proteins: ß-
endorphin (Mr 3.461) [34] and a rat seminal vesicle protein (SV-IV, Mr 9.758) [35]. 
While only one out of five lysyl residues in ß-endorphin acts as amine-donor for 
transglutaminase, six out of nine lysines in SV-IV can be involved in crosslinking. 
Whether the very selective use of Lys175 as an amine-donor substrate, out of 10 
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lysines present ¡η σΒ-crystallin, ¡s the rule rather than the exception, can only be 
decided after many more data from diverse biological systems have been obtained. 
In aged and cataractous human lenses the presence of e-(K-glutamyl)-lysine 
¡sopeptides has been demonstrated [29] . Whether and to what extent σΒ-crystallin is 
involved in such in vivo crosslinking processes remains to be elucidated. The possibility 
of transglutaminase-mediated crosslinking of oB-crystallin outside the lens, may have 
implications for its role as a stress protein [ 1 3 ] , in neurodegenerative disorders [7-10, 
36,] and in heart ischemia [ 3 7 ] . 
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CHAPTER 6 
The carboxyl-terminal lysine of the mouse small heat shock 
protein functions as an amine-donor substrate for 
tissue transglutaminase 
The data of this chapter have been published in: 
The Journal of Biological Chemistry (1993) 268,1046-1052 

THE CARBOXYL-TERMINAL LYSINE OF THE MOUSE SMALL HEAT SHOCK PROTEIN 
FUNCTIONS AS AN AMINE-DONOR SUBSTRATE FOR TISSUE TRANSGLUTAMINASE 
ABSTRACT 
Small heat-shock proteins (HSPs) are homologous with the vertebrate eye lens 
protein σ-crystallin, and increasing evidence indicates that these proteins also have 
functional similarities. Here, we report that mouse HSP25, like bovine oB-crystalhn, 
functions as amme-donor substrate for tissue transglutaminase. The carboxyl-terminal 
lysine in mouse HSP25, as in bovine oB-crystallin, was identified as the sole amme-
donor substrate site. 
INTRODUCTION 
Several years ago 11) it was discovered that the Drosophila small heat-shock 
proteins (HSPs) are structurally related to the vertebrate eye lens protein σ-crystallin, 
which is composed of the homologous σΑ- and oB-subunits. Besides the considerable 
sequence similarity, which is most pronounced in the carboxyl-terminal halves of σ-
crystallin and small HSPs, the proteins also resemble each other in quaternary structure 
[2-5]. Moreover, recent studies demonstrated that oB-crystallin behaves in several 
respects like the mammalian small HSPs. Both proteins are induced upon stress [6-8] 
and relocalize from the cytoplasm towards the nucleus after stress [6, 8-10]. Thus they 
are likely to serve similar functions. Very important in this respect has been the 
discovery that σΑ- and oB-crystallin not only are the most abundant eye lens proteins, 
but also occur constitutively in several cell types and organs outside the lens [11-15] 
To enable a further comparison between σ-crystallin and small HSPs, we 
analysed the ability of mouse HSP to serve as an amme-donor substrate for tissue 
transglutaminase, because oB-crystallin, though not oA-crystallin, has recently been 
found to be an amme-donor substrate for protein-crosslinking by tissue 
transglutaminase [16]. Bovine σΒ-crystallin differs, among others, from σΑ-crystallin in 
having 2 lysine residues at its carboxyl terminus [17]. It is indeed the carboxyl-terminal 
lysine of oB-crystallin, Lys175, that has been identified as the reactive amme-donor 
residue [16]. Since mouse HSP contains a carboxyl-terminal lysine too [18], it was 
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interesting to determine whether this lysine residue can serve as an amine-donor 
substrate as well. 
MATERIALS AND METHODS 
Isolation of Proteins 
σ-crystallin was isolated from the water-soluble fraction of calf lens cortex by 
gel permeation chromatography. σΑ- and oB-subunits were separated by ion-exchange 
chromatography on DEAE-cellulose [19]. Recombinant mouse HSP25 was expressed in 
E. coll BL2KDE3), using the expression clone pAK3038p25, as described by Gaestel et 
al. [18]. The mouse HSP25 was purified from the E. coli lysate essentially according to 
Gaestel er al. [20]. 
Determination of amine-donor substrate capacity for transglutaminase 
To study the lysine-substrate capacity in the transglutaminase-mediated 
crosslinking, purified σ-crystallin and HSP25 were treated with guinea-pig liver 
transglutaminase (Sigma) in the presence of a biotinylated amine-acceptor hexapeptide 
and analysed essentially as described by Groenen et al. [16]. 
Miscellaneous Methods 
Digestion of σ-crystallin and recombinant HSP25 with carboxypeptidase В 
(Merck) was performed as decribed by Siezen et al. [21]. Alkaline urea gel 
electrophoresis was carried out at pH8.5 [19]. SDS-polyacrylamide gel electrophoresis 
was performed according to Laemmli [22] and streptavidin blot analysis was performed 
as described by Groenen et al. [16]. 
RESULTS AND DISCUSSION 
Amine-donor substrates for transglutaminase can be identified using a 
biotinylated amine-acceptor peptide as a probe. Such a peptide inhibits the normal 
transglutaminase-mediated Gln-Lys crosslinking of polypeptides by blocking the lysine 
donors [23,24]. To examine whether mouse HSP would act as an amine-donor 
substrate, purified recombinant mouse HSP and, as a control, σ-crystallin, were 
incubated with tissue transglutaminase, Ca2* and the biotinylated amine-acceptor 
probe, and analysed as described in Materials and Methods. Obviously, HSP25 can be 
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Fig. 1. Lysine-substrate capacity of o-cry stall in and HSP25 in the transglutaminase-mediated 
crosslinking. Alkaline urea gel electrophoresis pattern (A) of mouse HSP25 (1 μς, lanes 1 and 2) 
and bovine σ-crystallin (20 μς, lanes 3 and 4) before (lanes 1 and 3) and after (lanes 2 and 4) 
carboxypeptidase В digestion. The distance between intact and truncated HSP25 (arrow) is 
approximately equal to the distance between intact and truncated σΒ-crystallin, demonstrating 
the loss of a single positive charge because of the removal of the carboxyl-terminal lysine 
residue (Groenen et al., 1992). Carboxypeptidase В does not affect σΑ-crystallin. SDS-gel 
electrophoretic pattern after Coomassie Brilliant Blue staining (B) or streptavidin blotting (C) of 
mouse HSP25 (lanes 1 and 2) and calf σ-crystallin (lanes 3 and 4) before (lanes 1 and 3) and 
after (lanes 2 and 4) digestion with carboxypeptidase B. Note that the loss of a single lysine 
residue in σΒ-crystallin, but less so in HSP25, leads to a detectably higher mobility in SDS-
PAGE. All samples have been incubated with Ca2*-activated transglutaminase and the amine-
acceptor probe. Comparison of the Coomassie Brilliant Blue pattern (B) and the corresponding 
streptavidin blot (C) shows that σΒ-crystallin and HSP25, but not σΑ-crystallin, are amine-donor 
substrates. Carboxypeptidase B-digestion results in the loss of the amine-donor capacity. 
Molecular masses of the markers (lane M) are indicated in kOa. 
decorated, like σΒ-crystallin, w i t h the biotinylated hexapeptide (Fig. 1, В and C, lanes 1 
and 3). This demonstrates that HSP25 can serve as an amine-donor substrate. To 
identify the reactive amine-donor residue, HSP25 and σ-crystallin were treated with 
carboxypeptidase В to remove the carboxyl-terminal lysine residue. The loss of a single 
positive charge, and thus the effectiveness of the digestion, is clearly demonstrated by 
alkaline urea gel electrophoresis (Fig. 1 A). Subsequent reaction w i t h the amine-acceptor 
probe and analysis by SDS-PAGE and streptavidin blot shows that both HSP25 and σΒ-
crystallin no longer react wi th the probe upon removal of the carboxyl-terminal lysine 
(Fig. 1 , В and С lanes 2 and 4). This convincingly demonstrates that the carboxyl-
terminal lysine in HSP25, as in σΒ-crystallin, serves as the sole amine-donor substrate 
site. 
The carboxyl-terminal sequences of HSP25 and σΒ-crystallin, being -Lys-Ser-Glu-
Gln-Ser-Gly-Ala-Lys-COOH [18] and -Ala-Val-Thr-Ala-Ala-Pro-Lys-Lys-COOH [17], 
respectively, do not exhibit any similarity in primary structure, indicating that tissue 
transglutaminase does not have very strict amine-donor substrate requirements. Our 
findings confirm in an indirect manner that the carboxyl-terminal lysines of HSP25 and 
σΒ-crystallin, being accessible for transglutaminase, are located in extended arms. It is 
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unclear what implications the substrate capacity for transglutaminase may have for σΒ-
crystalhn and HSP25 under normal conditions. It has been proposed that tissue 
transglutaminase activity is implicated in apoptosis [25, 2 6 ] , tumor progression (27], 
stimulated secretion [28] and receptor-mediated endocytosis [29]. These are processes 
which involve changes in the intracellular organization. The fact that oB-crystallin and 
small HSPs are also involved in cytomorphological changes [30-33] may provide a clue 
for the interactions between these proteins and transglutaminase. 
The findings that both HSP25 and σΒ-crystallin function as amine-donor 
substrates for tissue transglutaminase have been published together with other 
structural and functional similarities of bovine σ-crystallin and mouse small heat-shock 
protein [34]. These similarities include the secondary structure and stability towards 
urea dissociation at pH7.0. Furthermore, it is shown that HSP25, like σ-crystallin, can 
function as a molecular chaperone, by suppressing heat-induced aggregation of other 
proteins, and is an efficient inhibitor of elastase. 
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EXPOSURE OF BH-CRYSTALLIN TO HYDROXYLS RADICALS ENHANCES THE 
TRANSGLUTAMINASE SUSCEPTIBILITY OF ITS EXISTING AMINE-DONOR AND 
AMINE-ACCEPTOR SITES 
ABSTRACT 
BH-Crystallin was exposed to radiolytically-generated hydroxyl radicals at 
defined radical concentrations and its capacity to act as an amine-acceptor substrate 
and as an amine-donor substrate for transglutaminase were investigated. [ U C]-
Methylamine was used as a probe for labelling amine-acceptor sites; a novel 
biotinylated hexapeptide was used to label amine-donor sites. The results demonstrate 
that both primary amine incorporation and hexapeptide incorporation by 
transglutaminase are considerably increased after oxidative attack on the crystallin. The 
identity of the labelled subunits was established and it is shown that in both cases this 
increased incorporation is not due to the production of new substrates, but that the 
existing incorporation sites become more susceptible. Moreover, using the newly-
developed probe we could identify for the first time the major crystallin subunits active 
as amine-donor substrates (both before and after treatment) to be BB1-, ВАЗ- and BA4-
crystallin. These data support the proposal that oxidative stress and transglutaminase 
activity may be jointly involved in the changes found in lens crystalline with age and in 
the development of cataract. 
INTRODUCTION 
Oxidative stress is a major threat to the ocular lens in vivo. This stress originates 
both from oxidants present in the fluids surrounding the lens and from oxidants 
generated within the lens itself (Spector, 1985). Oxidative modifications have been 
shown to accumulate in the long-lived lens proteins, and this damage has been 
considered as one of the major factors contributing to ageing and cataractogenesis 
(Augusteyn, 1981; Harding, 1991). Oxidation-induced modifications of crystalline may 
lead directly to cross-linking of crystallins (McDermott era/., 1988; Zigler et a!.. 1989) 
and to a shift to more acidic crystallins (Garland et al., 1986), which are found in 
human lenses upon ageing and in senile cataract. It is known that oxidative damage to 
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proteins makes them more susceptible for proteolysis (Davies, 1987); this mechanism 
also operates on the eye lens crystalline (Carmichael et al., 1989). 
The discovery of transglutaminase activity in the lens of various mammalian 
species and of significant amounts of c-g'utamyl-f-lysine isopeptide bonds in 
cataractous lenses led to the suggestion that transglutammase-mediated changes may 
be important in the ageing of the lens and in cataractogenesis (Lorand et al., 1981) 
Transglutaminases are a group of Ca2+-dependent enzymes involved in the formation of 
e-(K-glutamyl)lysine isopeptide cross-links in polypeptides and in the conjugation of 
amines to certain glutamina residues in proteins. The latter glutamine sites are referred 
to as amme-acceptor sites and the lysine residues involved in polypeptide cross-linking 
are known as amine-donor or (in this paper) hexapeptide-mcorporation sites. Recently, 
it was demonstrated that exposure of crystalline to oxidizing free radicals also enhances 
their susceptibility to transglutaminase, as measured by primary amine incorporation 
(Brossa et al, 1990, Seccia et al, 1991). 
The enhanced susceptibility of crystallins to transglutaminase after free radical 
treatment could be due either to a generalized degradation of proteins, exposing 
additional and new substrate sites, or to structural changes that make the pre-existing 
substrate sites more accessible. To distinguish between these two possibilities, we 
studied the influence of hydroxyl radical modification on the transglutaminase substrate 
capacity of ßH-crystallin using probes for both amme-acceptor and amine-donor 
activity Using two-dimensional gel electrophoresis to identify the labelled polypeptides 
we demonstrate that oxidative stress does not lead to formation of new substrates but 
it increases the susceptibility of the existing transglutaminase substrates. 
In the bovine eye lens, three B-crystallin subunits (BB2-, ßB3- and ßA3-crystalhn) 
have previously been shown to act selectively as amme-acceptor substrates for 
transglutaminase (Berbers et al, 1984a) In the present study we have now identified 
also the amine-donor substrates for transglutaminase using a biotinylated amine-
acceptor peptide modelled on the sequence around the amme-acceptor glutamine 
residue in bovine ßA3-crystalhn (Groenen et a/,1992) as a probe. 
MATERIALS AND METHODS 
Exposure of crystallins to free radical 
BH-Crystallm was isolated from the water-soluble fraction of calf lens cortex by 
gel permeation chomatography over Ultragel AcA34 (Pharmacia LKB) as previously 
described (Groenen et al, 1992) It was dissolved in water at pH 7 0 at a 
concentration of 1 0 mg/ml and the solution saturated with N20 immediately prior to 
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exposure to the Brunei University eoCo source and irradiation at 4.93 Gy per mm. These 
conditions were chosen to generate specifically the hydroxyl radical (OH ), the 
concentrations of which can be calculated knowing the dose and the radiolytic yield 
(see Seccia et al, 1991). A 54 μΜ hydroxyl radical concentration, corresponding with 
1.45 mol OH per mol protein per 20 mins irradiation period, was chosen as pilot 
experiments indicated that this dose gave a maximum increase in transglutaminase-
mediated putrescme incorporation. After irradiation, protein samples were incubated 
with transglutaminase and labelled substrates as described below. 
Analysis of the amine-acceptor substrates 
The amine-acceptor substrate susceptibility of control and radical-treated BH-
crystallm was determined by measuring the transglutaminase-mediated Ca2+-dependent 
incorporation of 14C-methylamine into trichloroacetic acid-insoluble material The assay 
reaction mixture (150 μ\) contained 1 mg BH-crystallin (control or radical-treated), 50 
mM Tns/HCI pH 7 5, 100 mM NaCI, 20% glycerol, 8 mM CaCI2, 0.8 mM 
phenylmethylsulfonyl fluoride (Merck), 1 6 mM leupeptin (Sigma), 1 mM 14C-
methylamine (Amersham; 1 02 GBq/mmol) and 0.01 U of active guinea-pig liver 
transglutaminase (Sigma; specific activity 1 9 U/mg, purity 90%) These assay 
conditions are based on the protocol as decnbed by Lorand et al. (1981); glycerol 
enhances the transglutaminase-mediated amme-mcorporation into lens proteins After 2 
h of incubation, the reactions were stopped by the addition of 16 μ\ 200 mM EDTA. To 
identify which subunits were labelled, samples were analysed by two-dimensional gel 
electrophoresis (O'Farrell, 1975). Gels were stained with Coomassie brilliant blue and 
subsequently processed for autoradiography, dried and exposed to Kodac-X-Omat RP 
films for 3 days The radioactive spots were identified by superimposing the 
autoradiographs on the corresponding Coomassie blue stained gels To quantify the 
[uC]-methylamme incorporation, samples from control and hydroxyl radical treated ßH-
crystallin reaction mixtures (5 μ\). were precipitated with trichloroacetic acid (10% final 
concentration) The precipitates were washed twice with cold 6% trichloroacetic acid, 
dissolved in 0.3 ml 50 mM Tns/HCI pH 7.5, 100 mM NaCI, mixed with 4 ml of Aqua 
Luma Plus (Lumac) and counted in a Beekman Model 2800 liquid scintillation counter 
The increase in [14C]-methylamine incorporation in the radical-treated BH-crystallin 
above control activity was determined as' 
[14C1 -incorporation (radical-treated BH) - ["Cl-incorporation (control BH) 
[,4C]-incorporation (control BH) 
The reported values are the means of triplicate trichloroacetic acid precipitations of ßH-
crystallin reaction mixtures. 
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Analysis of the amine-donor substrates (hexapeptide incorporation) 
Control and radical-treated BH-crystallms were incubated with active 
transglutaminase (Sigma) and a biotmylated amine-acceptor hexapeptide (H-Thr-Val-Gln-
Gln-Glu-Leu-OH), as described by Groenen et al. (1992). Samples were analysed by 
SDS/PAGE (Laemmli, 1970) and two-dimensional gel electrophoresis (O'Farrell, 1975), 
followed by staining with Coomassie brilliant blue or streptavidin blot analysis (Groenen 
et al., 1992). Quantitation of the hexapeptide incorporation was performed in duplicate, 
scanning the one-dimensional pattern of streptavidin blots, loaded with serial dilutions 
of control and radical-treated ßH-crystallin reaction mixtures, with a LKB-Bromma 
Ultroscan XL Enhanced Laser Densitometer. 
RESULTS 
Analysis of amine-acceptor substrates 
The amine-acceptor substrates in control and hydroxyl radical treated BH-
crystallin were identified by selective transglutaminase-mediated incorporation of [UC1-
methylamine. Methylamine is the smallest possible substrate for transglutaminase and 
has the advantage of not producing noticable changes in molecular mass and charge of 
the proteins in which it is incorporated. The stained electrophoretical pattern and 
corresponding autoradiograph of control ßH-crystalhn incubated with [uC]-methylamine 
and transglutaminase (Fig. 1) show that three ß chains (ßB2-, ßB3- and ßA3-crystallin) 
have been labelled, in agreement with the data of Berbers et al. (1984a), although BB2-
crystallin is only weakly represented. Some modification products of BA3-crystallin are 
strongly labelled and some cross-linked products can also be detected. After hydroxyl 
radical treatment of ßH-crystallin and incubation with [14C]-methylamine and 
transglutaminase, the intensity of the same crystallins (BB2-, BB3- and BA3-crystallin), 
including the crosslinking products, is increased; no other ß-crystallin chains become 
labelled (Fig 1). The substrate capacity of control and radical-treated ßH-crystallin was 
determined by measuring the [14CJ-methylamine incorporation of the reaction mixtures. 
In hydroxyl radical-treated BH-crystallin, an increase of 77 ± 10% above control 
activity was observed. No incorporation of [14C]-methylamine was found in the absence 
of transglutaminase or in the absence of Ca2*, neither in radical-treated ßH-crystalhn 
nor in control ßH-crystallin (data not shown). 
Analysis of amine-donor substrates 
Control and hydroxyl radical treated ßH-crystallin samples were incubated with 
the biotmylated amine-acceptor probe and analysed by two-dimensional gel electro-
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Fig. 1. Identification of amine-acceptor substrates in bovine ßH-crystallin, before (1) and after 
(2) exposure to hydroxyl radicals (54 μΜ OH). (A) Coomassie brilliant blue-stained two-
dimensional gel patterns, (B) the corresponding autoradiographs after incubation of BH-
crystallins with transglutaminase and [,4C]-methylamine. 200 /yg of protein was applied to the 
first dimension. Isoelectrofocussing is in the horizontal direction, with the basic side on the left 
and the acidic side on the right, SDS-gelelectrophoresis is in the vertical direction, from top to 
bottom. Major crystallins and crosslinking products (CL) are indicated on the stained gels. Spots 
indicated by asterisks are probably posttranslational modifications of BB2- and ßA3-crystallin. 
Polypeptides that were found to be labelled with [,4C)-methylamine are shown on the 
autoradiographs (B). 
phoresis. The positions of the subunits in this separation system are well established 
from our previous work (Berbers et al., 1984b). The stained electrophoretical pattern 
and corresponding streptavidin blot are rather complex, as binding of the amine-
acceptor probe increases the molecular mass and lowers the pi of the substrate 
crystallins. Nevertheless, the identity of the labelled subunits can be deduced from the 
positions of the peptide-decorated products relative to the unmodified subunits and, in 
the case of ßB1-crystall in, from the use of a specific antiserum. The positions of the 
streptavidin-positive spots demonstrate that BB1-, ßA3- and ßA4-crystallins are the 
subunits that serve as amine-donor substrates for transglutaminase. The involvement of 
ßB1-crystallin was confirmed by the positive response of a set of these spots to 
antiserum specific for this protein. It appears that both the primary gene product ßB1a, 
its naturally-occurring truncated form ßB1b, and also their differently-charged forms, all 
react wi th the hexapeptide probe. The pattern of the hexapeptide-decorated ßB1-
crystallin subunits on the streptavidin blot (Fig. 2) indicates that it contains multiple 
lysine substrate sites for transglutaminase; this is in accordance with the known 
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Fig. 2. Identification of amine-donor substrates in bovine ßH-crystaliin, before (1) and after (2) 
exposure to hydroxyl radicals (54 μΜ OH ). (A) Coomassie brilliant blue-stained two-dimensional 
gel patterns, (B) the corresponding streptavidin blots after reaction of BH-crystallin with 
transglutaminase and the biotinylated amine-acceptor probe. 150 μα and 30 μα of protein were 
applied to the first dimension for A and B, respectively. The directions for SDS and IEF are 
given in Fig. 1. Major crystallins and crosslinking products ICD are indicated on the stained 
gels. Arrows indicate the peptide-decorated products of SB1- and ßA3-crystallin, which 
correspond in position with the spots on the streptavidin blots. The blot procedure reveals the 
microheterogeneity of ßB1-, ВАЗ- and ßA4-crystallin, probably due to posttranslational 
modifications , which are indicated by asterisks on the stained gel. Decorated ßBI-crystallin 
spots of different molecular masses indicate the presence of multiple lysine sites in ßBI-
crystallin. Additional minor spots on the blot have not been identified. 
presence of four lysine residues in the N-terminal extension (Mulders et al., 1987). 
Antisera against ßA3- or ßA4-crystallin were not available but purification of 
these subunits and incubation w i th the probe and transglutaminase confirmed their 
ability to act as amine-donor substrates (data not shown). The relative intensities of the 
hexapeptide-decorated subunits on the streptavidin blot (Fig. 2B), indicate that ßB1-
and ßA3-crystallins are better amine-donor substrates for transglutaminase than ßA4-
crystallin. The binding of the amine-acceptor probe to the substrate proteins seems to 
cause a much greater shift in ßB1a/b-crystallin than in the other polypeptides. This may 
be due to a discontinuous pH-gradient on the basic side during isoelectrofocussing. 
Moreover, ßB1a/b-crystallins have a long N-terminal extension, mainly composed of 
repeating Pro-Ala sequences, which are supposed to induce extraordinary 
conformational properties that influence the electrophoretic mobility (Berbers et al., 
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Fig. 3. Enhancement of amine-donor 
Substrate activity of ßH-crystallin after 
exposure to hydroxyl radicals. (A) 
Streptavidin blot, showing serial dilutions 
of (a) control and (b) hydroxyl-radical 
treated BH-crystallin, labelled by reaction 
with transglutaminase and the biotinylated 
amine-acceptor probe. Amounts of protein 
applied on the gel: (1) 1.33 μα. (2) 1.00 
μα, (3) 0.67 μα, (4) 0.50 μα. (5) 0.33 μα 
and (6) 0.25 μα- (Β) Densitometrie pattern 
of lane 2a (1.00 μα control BH) and lane 
5b (0.33 μα radical treated BH). 
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1983). Decoration of the lysine substrate(s) in this sequence may therefore lead to a 
more drastic change in the apparent pi of the proteins than expected. 
The finding of ВАЗ-crystallin as amine-donor substrate for transglutaminase is 
particularly interesting, because evidence was provided earlier that QA3-crystallin can 
function as amine-acceptor substrate as well (Berbers et al., 1984a). The presence of 
multiple substrate sites within certain crystallins, like in ßA3- and in QB1-crystallin, 
probably explains the labelling of the crosslinking products that is found upon 
incubation with [14C]-methylamine (Fig. 1) and with the biotinylated amine-acceptor 
probe (Fig. 2). 
Comparing the electrophoretic patterns (both stained gels and corresponding 
streptavidin blots) of control and hydroxyl radical-treated ßH-crystallin samples, reveals 
that the polypeptides that are labelled are essentially the same, but the intensity of the 
streptavidin-positive spots is increased in the oxidized sample (Fig. 2). Spontaneous, 
transglutaminase-independent incorporation of the biotinylated hexapeptide in control or 
radical-treated ßH-crystallin does not occur (data not shown). To quantitate the 
increase in lysine-substrate capacity, serial dilutions of control and radical-treated ßH-
crystallin reaction mixtures were analysed on a one-dimensional SDS/PAGE gel and the 
intensities of the bands on the streptavidin blot were measured by laser densitometry. 
In Fig. 3, it can be seen that lane 2a (ßH-crystallin: 1.0 μφ has about the same 
intensity as lane 5b (ßH-crystallin, radical- treated: 0.33 μg). Therefore, it may be 
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concluded that the amme-donor capacity of ßH-crystallin has increased by 
approximately 3-fold following oxidative attack. 
DISCUSSION 
In a previous study (Seccia et al, 1991), we demonstrated that exposure of ßL-
crystallm to various oxidizing free radicals enhanced its capacity as an amme-acceptor 
substrate for transglutaminase In this study we have used SH-crystallin (which differs 
from ßL-crystallin only in the presence of the additional ßB1-subunits) and 
demonstrated that only the transglutaminase susceptibility of those ß-crystallins that 
already served as substrates, is enhanced This was the case both for the glutamme 
substrates labelled with (1*C]-methylamme and for the lysine substrates labelled with 
the biotinylated amme-acceptor probe 
The use of the biotinylated hexapeptide probe, in combination with two-
dimensional gel electrophoresis, has enabled us to identify the amme-donor substrates 
for transglutaminase among the ß-crystallins These are found to be the ßB1-, ВАЗ- and 
ßA4-crystallin subunits as well as some minor subunits It may be emphasized that this 
is one of the very first instances in which the use of amme-acceptor peptides, a 
technique proposed by Parameswaran et al (1990), has led to the identification of 
amme-donor substrate proteins for transglutaminase The only other reported 
substrates identified with this approach are oB-crystallin (Groenen et al., 1992; Lorand 
et al, 1992), heat shock protein HSP25 (Merck et al, 1993), and the elastase inhibitor 
elafin (Molhuizen et al., 1993) 
The identified glutamme (amme-acceptor) sites in ßB2-, ßB3- and ßA3-crystallms 
(Berbers ef al., 1984a) and the inferred lysine (amme-donor) sites in ßB1-crystalhn 
(Mulders et al., 1987) are all located in N-terminal extensions of the proteins This 
region extends from the compact two-domain structure of the ß-crystallins (Wistow ef 
al, 1981, Bax et al., 1990) It is unlikely that, upon oxidation of the Q-crystallin, 
glutamme and lysine residues in the conserved domain regions of the protein become 
accessible for transglutaminase, as this would cause substrate labelling in all ß-
crystallins present. The enhanced transglutaminase substrate capacity of the existing 
amme-acceptors and amine-donors in the ß-crystallins therefore likely results from a 
more efficient interaction between the enzyme and the substrate sites, probably due to 
subtle conformational changes and/or modification of specific amino acid residues in 
the oxidized protein Conformational changes due to photo-oxidation have indeed been 
observed in calf lens ßH-crystallin (Andley ef al, 1988) The actual sites of hydroxyl 
radical attack on ß-crystallins are unknown. Virtually all residues would be susceptible 
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to attack by this extremely reactive free radical, although tryptophan, tyrosine, histidme 
and cysteine residues have been considered particularly susceptible residues in other 
proteins (Davies et al., 1987) In parallel experiments with BH-crystallin to those 
reported here, we observed (K.H C, M.S. and J. Boateng, unpublished data) that 54 μΜ 
hydroxyl radical induced a 20% loss in tryptophan fluorescence and a 2 5 % decrease in 
protein thiol content. Apparently, this level of side chain damage still leaves the main 
protein domains essentially intact, since substantial unfolding of the proteins would be 
expected to cause susceptibility for substrate incorporation in all crystalline present 
Histidme damage was not measured here, but preferential photo-oxidation of histidme 
residues has been reported for lens crystallins (Li et al., 1990, McDermott et al, 1991) 
and histidme residues are located close to the amine-acceptor glutamme residues in 
ßB2- and ßB3-crystalhn (Berbers et al., 1984b) It is conceivable that oxidative 
modification of these histidme residues enhances the binding of the substrate to the 
active site of transglutaminase. 
Our observations lend support to the proposal that the generation of oxidizing species 
within the eye lens, due to exposure to free radical generating systems or to deficiency 
of natural antioxidant compounds, may act together with endogenous transglutaminase 
activity to cause aggregation of ß-crystallins leading to the pathological changes 
associated with ageing and with senile cataract It is also possible that this observation 
might have more general applicability, in that other proteins in other tissues may 
become more susceptible to transglutaminase activity following attack by oxidizing free 
radicals Our observations strongly suggest that such proteins would already be 
substrates for this enzyme 
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LYS17 IS THE AMINE-DONOR SUBSTRATE SITE FOR TRANSGLUTAMINASE IN BA3-
CRYSTALLIN 
ABSTRACT 
The bovine lens protein, ßA3-crystallin, has recently been shown to be an 
amine-donor (Lys) substrate for tissue-type transglutaminase, using a newly-developed 
amine-acceptor hexapeptide as a probe [1]. In the present study, the reactive amine-
donor site has been identified by site-directed mutagenesis of the putative substrate 
lysine. The mutation Lys17Arg abolishes the substrate capacity. This residue, located in 
the N-terminal extension of the polypeptide, thus acts as the sole amine-donor 
substrate in ßA3-crystallin. Our finding reinforces the notion that, in the crystallins, all 
amine-donor as well as amine-acceptor substrate sites reside in the N- or C-terminal 
arms. Transglutaminase-mediated crosslinking of ßA3-crystallin also gives rise to a 
ВАЗ-dimer due to the fact that Lys 17 can be crosslinked to the previously established 
Gln7 or 8 amine-acceptor site. 
INTRODUCTION 
Transglutaminases catalyze a Ca5+-dependent acyl transfer reaction between the 
p-carboxamide group of a peptide-bound glutamine residue, acting as amine-acceptor 
substrate, and the e-amino group of a peptide-bound lysine residue, acting as amine-
donor substrate. This reaction results in the formation of κ-glutamyl-e-lysine crosslinks 
in or between polypeptides [for review, see 2, 3]. Tissue-type transglutaminase, which 
occurs in most cell types, is a monomeric protein with a molecular mass of 75-80 kDa 
[41. Although the physiological role for this transglutaminase is unknown, it has been 
implicated in receptor-mediated endocytosis [5], in hormone secretion [6], in 
maintenance of the non-proliferative state of cells [7, 8], in the program of 
physiological cell death [9, 10] and in the development of cataract in human lenses [ 1 1 , 
12]. Very little is known about the in situ substrate requirements for the enzyme. 
Eye lens crystallins are among the best studied substrates for tissue 
transglutaminase. In the bovine lens, three ß-crystallins (BB2-, BB3- and ßA3-
crystallins) have been identified as amine-acceptor substrates for tissue 
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transglutaminase [13]. Recently, the amine-donor substrates among the bovine lens 
proteins were identified using a biotinylated amine-acceptor hexapeptide, which was 
modelled on the sequence around the amine-acceptor glutamine residue in bovine QA3-
crystallm | 1 , 14]. It was demonstrated that σΒ-crystalhn and several ß-crystallins, 
notably BB1-, ВАЗ- and BA4-crystallins, selectively act as amine-donor substrates for 
transglutaminase. We speculated that in ВАЗ-crystallin a lysine at position 17 in the N-
terminal arm, which extends from the compact two-domain structure of this protein, is 
the amine-donor site. This assumption was based on the observation that, in contrast 
to ßA3-crystallm, BA1-crystallin does not detectably act as an amine-donor substrate 
[1]. ßA1-crystallin has a 17 residues shorter N-terminal arm as compared with BA3-
crystallin, but these proteins are otherwise identical, being translated from the same 
mRNA [15, 16]. The putative substrate lysine in ßA3-crystallin would thus not be 
present in ßA1-crystallm. However, it cannot be excluded that an other lysine residue 
of ВАЗ-crystallin serves as the actual amine-donor substrate, since QA3-crystallin may 
undergo structural changes due to the presence of its 30 ammo acid long N-terminal 
extension, thereby making other sites accessible for transglutaminase. To examine 
whether the lysine residue in the N-terminal extension of ßA3-crystallm acts as an 
amine-donor substrate, a site-directed mutant was made in which the putative 
substrate lysine was replaced by an arginine. Analysis of the amine-donor substrate 
capacities of wild-type and mutant ßA3-crystallin proves that Lys 17 acts as the sole 
amine-donor substrate for tissue-type transglutaminase. 
MATERIALS AND METHODS 
Construction of expression plasmids of wild-type and mutant BA3-crystallin 
For the construction of a ßA(1+3)-crystalhn cDNA clone the 3' incomplete 
bovine cDNA clone pBLßAd+3) [16] and the 5' incomplete rat cDNA clone 
/tgt11ßA(1 +3) [17] served as starting material. Details of the procedure are described 
in Fig. 1. The resulting pBSßAd +3) cDNA clone encodes a hybrid bovine-rat ВАЗ/А 1-
crystallin. The first 47 residues, including the N-terminal arm and part of the N-terminal 
domain, are bovine, the remainder has the rat sequence. Because of the evolutionary 
conservation of this protein, the encoded sequence can be considered as the bovine 
ВАЗ-crystallin sequence with only 5 amino acid replacements in the domain regions, 
viz.. N29S, V44I, V57I, P124F and S170T [17]. 
Site-directed mutagenesis was used to alter the putative amine-donor substrate 
lysine for transglutaminase into an arginine residue The pBSBAd+3)del clone (Fig. 1 ) 
was mutated according to Taylor et al [18] using the oligonucleotide-directed m vitro 
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EcoRV Ndel EcoRI Ncol EcoRI BamHI 
*£ *¡? pBSQA(1*3) 
— — • ~1 
arm domain 1 domain 2 
ПАЭ-crystalI In 
Fig 1 Schematic representation of the complete ВАИ +3) cDNA clone (A) Coding sequence of 
bovine BA(1 + 3)-crystalhn M , coding sequence of rat BAd + 3)-crystalhn EH , noncoding 3' 
sequence , pBluescnpt sequences Restriction sites and BA3/A1 start codons are 
indicated For the construction of this complete ВАЗ/А 1-crystallin cDNA clone, the insert of the 
bovine pBLBAd +3) cDNA clone (16) was transferred to pGEM2 and mutated just upstream 
from the start codon to introduce an Ndel site This was done by a polymerase chain reaction, 
using a specific mutagenic oligonucleotide (CCCCATATGGAGACCCAGACTGTGCAG) and a 
vector oligonucleotide (T7 primer) The PCR-product was digested with EcoRI and the resulting 
blunt end-EcoRI fragment (142 n) was cloned in an EcoRV-EcoRI-digested pBluescnpt II SK* 
vector, generating pBSBAd +3)del The insert of the rat /tgt11ßA(1 +3) clone (17) was cloned 
in pBluescnpt II SK*, producing pBSr&Ad +3), and mutated to introduce an EcoRI site at codon 
position 9 (corresponding with codon position 47 of the entire BAd +3) coding sequence) This 
mutation was generated by a polymerase chain reaction using a specific mutagenic 
oligonucleotide (AGGATGGAATTCACCAGC) and a vector oligonucleotide (M13 reversed 
primer) The PCR product was digested with Ncol and the resulting blunt end-Ncol fragment 
(316 n) was cloned the Hincll-Ncol-digested pBSrBAd +3) The resulting clone was digested 
with EcoRI and the obtained EcoRI fragment (625 n) was cloned in the EcoRI-digested 
pBSBAd +3)del, to produce pBSBAd +3) Both PCR-products were sequenced by the dideoxy-
nucleotide method (19), to check whether the mutations were introduced correctly. Schematic 
representation of the encoded ВАЗ/А 1-crystalhn (B) Protein sequence derived from the bovine 
coding sequence •• , protein sequence derived from the rat coding sequence • , * marks the 
position of Lys 17 The structural domains and the N-termmal arm of the B-crystallin polypeptide 
are indicated 
mutagenesis system of Amersham (Nederland В V., Houten, The Netherlands). The 
coding oligonucleotide CCAACCACCAGGATGGCTCAAACT, which was synthesized 
using a Cyclone Plus DNA synthesizer from Eurogentec S.A. (Seraing, Belgium), 
resulted in the mutation K17R in the N-terminal extension The mutated 142 base pair 
fragment was sequenced by the dideoxynucleotide method [19], using the double-
stranded KiloBase Sequencing System (Bethesda Res. Labs. Life Techn., Inc., 
Gaithersburg, MD/USA), to confirm the presence of the desired mutation and the 
absence of unwanted changes The rat EcoRI-EcoRI fragment (625 n) (Fig 1) was then 
cloned in the right orientation in the EcoRI-cleaved pBSßAO +3)del,K17R construct to 
complete the ßA3/A1-crystallin coding sequence. 
For overexpression of recombinant wild-type and mutant ВАЗ-crystallin, the 
Ndel-BamHI fragments (783 n) (Fig. 1) of the wt and K17R p B S B A d + 3 ) clones, 
comprising the entire coding and 3' non-coding sequence, were cloned in Ndel-BamHI-
cleaved рЕТЗЬ resulting in pET3bßA(1 + 3 ) w t and рЕТЗЬВАИ+31K17R, respectively. 
Expression of wild-type and mutant SA3-crystallin in the host E. coli BL2KDE3), and 
preparation of the water-soluble fraction were performed essentially as described by 
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Merck et al. [20] . After desalting, using Filtron Microsep concentrators, the water-
soluble fractions were lyophilized. The apparent molecular mass of the expressed 
proteins was estimated by SDS-polyacrylamide gel electrophoresis [21]. Expression 
levels were quantitated by scanning of Coomassie-Brilliant blue stained gels using an 
LKB-Bromma Ultroscan XL Enhanced Laser Densitometer. 
Analysis of transglutaminase amine-donor substrate capacity 
To study the amine-donor (lysine) substrate capacity in the transglutaminase-
mediated crosslinking, the water-soluble fractions of the bacterial lysates (0.5 mg 
protein), containing the wild-type and mutant ßA3-crystall ins, were incubated wi th 5 
mU guinea-pig liver transglutaminase (Sigma; specific activity 1.9 U/mg, purity 90%) 
and a biotinylated amine-acceptor hexapeptide (H-Thr-Val-Gln-Gln-Glu-Leu-OH; final 
concentration 1.6 mM) in a volume of 63 ¡A, as described by Groenen et al. [14] . 
Reaction mixtures were analysed by SDS-PAGE [21] fol lowed by staining wi th 
Coomassie Brilliant blue and streptavidin blot analysis [14] . 
RESULTS AND DISCUSSION 
Induction of the pET3bßA(1+3) wild-type and K(17)R-mutant clones in E. coli 
both resulted in the expression of a polypeptide wi th an apparent molecular mass of 
28.5 kDa (Fig. 2A, lanes 2 and 4), corresponding wi th the molecular mass of the ßA3-
subunit isolated from calf lenses. Induction of the pET3bßA(1 +3 ) clones did not result 
in the production of a 23 kDa ßA1-polypeptide, indicating that the second start codon 
has not been used, which might be due to the fact that the ribosome-binding site of the 
vector is located about 55 bases upstream from the ßA1 start codon. Expression levels 
of wild-type and mutant ßA3-crystallin were about 3 5 % of the total protein as 
estimated by gel scanning. 
Incubation of the induced pET3bßA(1 + 3 ) w t bacterial lysate in the presence of 
Fig. 2. Overexpression of ßA3-crystallin ¡η E. coli. 
Coomassie-Brilliant blue stained protein pattern after 
SDS-polyacrylamide gel electrophoresis. Samples are: 
Total protein of E. coli BL2KDE3) containing plasmid 
р Е Т З Ь В А М + 3) w t ( lanes 1 and 2) and 
рЕТЗЬВАП +3)K17R (lanes 3 and 4), before (lanes 1 
and 3) and after induction (lanes 2 and 4). Total B-
crystallin from calf lens cortex is loaded as a control 
(lane 5), and some specific ß-crystallin subunits are 
indicated. Molecular mass markers (in kDa) are 
indicated. Arrowheads indicate the expressed proteins. 
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transglutaminase, Ca2 + and the biotinylated amine-acceptor hexapeptide leads to the 
covalent binding of the probe to the wild-type ßA3-crystall in (Fig. 3 A/B, lanes 1 and 
2), demonstrating that recombinant ВАЗ-crystallin from E. coli, like ВАЗ-crystallin from 
bovine lenses (Figi ЗА/В, lane 6), functions as an amine-donor substrate for 
transglutaminase. Binding of the hexapeptide probe, w i t h a molecular mass of 1050 
kDa, to ВАЗ-crystallin results in the expected decrease in mobility on SDS-PAGE. The 
apparent molecular mass increases from 28.5 to 29.5 kDa. A product w i t h an apparent 
molecular mass of 52.5 kDa was also decorated w i t h the amine-acceptor probe (Fig.3 
A/B, lane 2). This product most probably is a dimer of ßA3-crystall in since it reacts 
wi th an antiserum against ß-crystallines and ВАЗ-crystallin does indeed function both 
as an amine-acceptor substrate [13] and as an amine-donor substrate [ 1 ] . Also the 
dimer (" in Fig. ЗА, lane 2) exhibits a decreased mobility upon reaction w i t h the 
hexapeptide probe. As the reaction of the recombinant ВАЗ-crystallin w i t h 
transglutaminase and the amine-acceptor probe leads to a peptide-decorated product 
and to a crosslinked ВАЗ-dimer, the amount of the recombinant ВАЗ-crystallin on SDS-
PAGE (Fig. ЗА, lane 2 versus 1) is drastically reduced. 
To examine whether or not the lysine residue in the N-terminal extension of 
ВАЗ-crystallin serves as the reactive amine-donor substrate, site-directed mutagenesis 
was performed to change the putative lysine substrate residue into an arginine residue. 
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Fig. 3. Lysine-substrate capacity of wi ld-type and mutant БАЗ crystall in in transglutaminase 
mediated crossl inking. Coomassie-Brilliant blue stained SDS-polyacrylamide gel (A) anc 
corresponding streptavidin blot (B). Proteins were incubated in a reaction mixture containing 
C a 2 4 and the biot inylated amine-acceptor probe w i t h o u t (lanes 1, 3 and 5) or w i t h (lanes 2, 4 
and 6) the addit ion of guinea-pig liver transglutaminase. Samples are: The water-soluble 
fractions of E. coli expressing рЕТЗЬВАИ + 3 ) w t (lanes 1 and 2; 5 ¿/g in A and Β) οι 
pET3bßA(1 + ЗЖ17Р, (lanes 3 and 4; 5 |/g in A and B), and total calf lens ß-crystallin (lanes E 
and 6; 2.5 /yg in A and Β), β-Crystal lin s that act as amine-donor substrates are indicated by the 
prefix d.(B; lane 6) . The ßA3-dimer is indicated by an asterisk (A; lane 2) and the peptide-
decorated BA3-crystal l in (A/B; lane 2), the ßA3-dimer (A/B; lane 2), and the peptide-decorated 
ßB1 a- and ßA3-crystal l ins of calf lens ßH (A; lane 6) are indicated by arrowheads. Molecular 
mass markers (in kDa) are indicated in lane M. 
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The resulting рЕТЗЬВАИ +3)K17R clone was expressed in E. coli and the lysate 
subsequently incubated with transglutaminase, Ca2* and the biotinylated amine-
acceptor peptide. Analysis of the reaction products by SDS-PAGE and streptavidin blot 
analysis clearly demonstrates that the mutant ВАЗ-crystallin no longer reacts with the 
amine-acceptor probe (Fig. 3A/B, lanes 3 and 4), even upon prolonged staining of the 
blot. 
Direct identification of the amine-donor substrate site in ßA3-crystallin would, of 
course, be more preferable. We have attempted such an approach by performing biotin-
streptavidin affinity chromatography to select the hexapeptide-decorated lysine 
substrate peptides out of a total ß-crystallin digest, but this method turned out to be 
technically unfeasible. A comparable method using anti-dansyl antibody affinity 
chromatography was attempted by Lorand and coworkers [22]. However, out of a 
digest of total lens proteins, they only could isolate the C-terminal peptide of aB-
crystallin as amine-donor substrate. Amine-donor substrate sequences from the ß-
crystallins were not identified. 
Using site-directed mutagenesis we now have been able to show that Lys17, 
located in the N-terminal extension, acts as the sole amine-donor substrate site in &A3-
crystallin. Also the two possible amine-acceptor substrates Gln7 and 8 reside in this 
extended arm of ВАЗ-crystallin [13], which protrudes from the compact two-domain 
structure of the ß-crystallins [23, 24]. The transglutaminase-mediated dimer formation 
of ßA3-crystallin implies that the N-terminal arms of two ßA3-subunits have the 
possibility to interact with each other. X-ray crystallographic analysis of the 
homologous ßB2-homodimer has revealed that the N-terminal domain of one subunit 
interacts with the C-terminal domain of the other subunit and vice versa [25]. The N-
terminal arms of the subunits thus extend from opposite sides of the dimer. Yet, the 
terminal extensions have been shown to be accessible to solvent and to flex freely from 
the globular domains of the proteins [25, 26], making contact between the 30-residue 
long N-terminal arms of two BA3-crystallins quite plausible. 
The selective use of Lys 17 as the sole amine-donor substrate, out of the 9 
lysines present in bovine BA3-crystallin [27], strengthens the notion that, at least in the 
crystallins, the lysine as well as the glutamina substrate residues must be located in 
accessible terminal extensions of the proteins. In addition to this accessible location, 
there may also be some degree of sequence specificity, since bovine BB2- and BB3-
crystallin, which contain a lysine residue in their N- and/or C-terminal extensions, do 
not detectably act as amine-donor substrate for transglutaminase [1]. There are only a 
few substrate proteins in which the amine-donor sites have been identified, notably in 
ßB1-, σΒ- and ВАЗ-crystallin [28, 14, 22, this study] and outside the lens in B-
endorphin [29], rat seminal vesicle protein [30] and in the small heat shock protein 
HSP25 [31]. Examination of the amino acid sequences surrounding the reactive lysine 
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residues in these substrate proteins, does not reveal a consensus sequence for this 
modification. Identification of more amine-donor substrate sites in native proteins will 
eventually contribute to a better understanding of the lysine substrate requirements of 
the enzyme transglutaminase. 
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THE AMINE-DONOR SUBSTRATE SPECIFICITY OF TISSUE-TYPE 
TRANSGLUTAMINASE 
Influence of amino acid residues flanking the amine-donor lysine 
ABSTRACT 
The amine-donor substrate specificity of tissue-type transglutaminase has been 
studied in a series of recombinant σΑ-crystallin mutants. These mutant proteins have 
been provided with a potential substrate lysine residue, flanked by different amino acid 
residues, in the C-terminal extended arm of σΑ-crystallin. A biotirtylated amine-acceptor 
hexapeptide was used as a probe for labelling the amine-donor sites. Wild-type bovine 
σΑ-crystallin does not function as an amine-donor substrate for tissue-type 
transglutaminase. Yet, upon introduction of a lysine residue at the C-terminal or 
penultimate position, all mutant σΑ-crystallins act as amine-donor substrates, although 
to different extents. This shows that accessibility is the primary requirement for a 
lysine residue to function as an amine-donor substrate for transglutaminase and that 
the enzyme has a broad tolerance towards the neighbouring residues. However, the 
nature of the flanking amino acid residues does clearly affect the reactivity of the 
substrate lysine. Notably, we found that a proline or glycine residue in front of the 
substrate lysine has a strong adverse effect on the substrate reactivity as compared to 
a preceding leucine, serine, alanine or arginine residue. 
INTRODUCTION 
Transglutaminases are Ca2+-dependent enzymes involved in the posttranslational 
modification of proteins. These enzymes catalyse the covalent coupling of the γ-
carboxamide group of peptide-bound glutamine residues (acting as amine-acceptors) 
with free primary amines or with the f-amino group of peptide-bound lysine residues 
(acting amine-donors). There is substantial evidence that this reaction proceeds through 
an acyl-enzyme intermediate, formed between the active site cysteine residue of the 
enzyme and the glutamine acyl-group. Amine-donor substrates only enter the reaction 
after formation of this acyl-enzyme complex. Transglutaminase action thus can result in 
protein crosslinking via κ-glutamyl-f-lysine isopeptide bonds, which are highly resistant 
to chemical and enzymatic degradation (for reviews: Folk 1983; Lorand and Conrad, 
1984). The physiological role of the most wide-spread representative of these enzymes, 
the tissue-type transglutaminase is poorly understood. It has been implicated in a 
variety of important biological processes (for review: Greenberg et al., 1991) and m 
degenerative diseases such as cataract (Lorand et a!.. 1981; McFall-Ngai et al., 1986). 
In relation with the various biological functions of transglutaminases, it is important to 
understand the substrate requirements of the enzyme. 
The sequence specificity around glutamine and lysine substrate sites for 
transglutaminases has been studied using model peptides (Gross et al., 1977; Gorman 
and Folk, 1981, 1984), but little is known about the manner in which these enzymes 
operate on native protein substrates m biological systems. Studies have indicated 
(Gorman and Folk, 1981) that the structural features of the protein may influence the 
effectiveness of the enzyme-substrate interaction. Hence, it is of interest to analyse the 
substrate specificity of transglutaminase in protein substrates. A number of glutamine 
and lysine protein substrates has been characterized. Among the bovine lens crystalline, 
it has been shown that three ß-crystallin subunits (QB2-, BB3- and QA3-crystallin) 
function selectively as amine-acceptors for transglutaminase (Berbers et al., 1984). 
From the identified glutamine sites of these substrate crystalline, and from the limited 
number of reactive glutamines identified in other proteins (Aeschhmann era/., 1992), it 
is not possible to derive a consensus sequence for transglutaminase amine-acceptor 
substrates. Even less information is available about the amine-donor protein substrates 
for transglutaminase, mainly due to the lack of a convenient probe. However, recently, 
the use of glutamme-containing oligopeptides as probes for amine-donor substrates has 
been described (Parameswaran ef al., 1990). In a similar manner, we were able to 
identify the amine-donor substrates in the bovine lens, using a biotinylated amine-
acceptor hexapeptide modelled on the sequence around the amine-acceptor glutamine 
residue in BA3-crystallm. It was found that three specific ß-crystallins, notably &B1-, 
ВАЗ- and BA4-crystallms, as well as αβ-crystallin selectively act as amine-donor 
substrates for transglutaminase (Groenen et al., 1992, 1993a). The site of crosslinking 
has been established in oB-crystallin, revealing that out of the 10 lysines present in ав-
crystallin, the C-terminal lysine residue serves as the sole amine-donor (Groenen et al., 
1992; Lorand étal., 1992). 
oB-crystallin is one of the two types of subunits in the large water-soluble a-
crystallin aggregate in the lens. The two homologous σΑ- and oB-crystallins, which are 
173 and 175 residues in length, respectively, show approximately 55% sequence 
identity (Bloemendal, 1981). These σ-crystallin subunits share most of their structural 
and functional properties (Merck et al., 1993; de Jong et al., 1993). However, σΑ-
crystallin, which lacks the C-terminal lysine that makes oB-crystallin a substrate for 
transglutaminase, does indeed not function as an amine-donor substrate for this 
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enzyme. The amine-donor lysine residue of σΒ-crystallin is located at the end of a 
flexible surface-exposed C-terminal arm, which extends from the proposed two-domain 
structure of the protein (Wistow 1985; Carver et al., 1993). We wondered whether the 
mere introduction of a C-terminal lysine in σΑ-crystallin would make it a suitable 
substrate for transglutaminase. This would indicate whether or not, in addition to the 
accessibility of the substrate lysine, also the adjoining compact protein surface is 
important for the substrate suitability of a protein for transglutaminase. If, as it turned 
out to be the case, σΑ-crystallin became a substrate for transglutaminase by the 
introduced C-terminal lysine, additional mutants could be made to study the effects of 
the directly flanking residues on the substrate capacity of a lysine in a native protein. 
Our results demonstrate that transglutaminase has a broad tolerance towards amine-
donor substrates, although the surrounding amino acid sequence definitely affects the 
reactivity of the lysine as an amine-donor residue. 
MATERIALS AND METHODS 
Bacterial strains, plasmids and reagents 
E. coli strains JM109 and TG1 were used as recipients for the pET8c and pGEM 
plasmidconstructs in the cloning experiments. For overexpression of recombinant 
proteins E. coli BL21(DE3).pLysS was used. Ampicillin, chloramphenicol, isopropylthio-
ß-D-galactoside (IPTG), chicken egg white lysozyme, DNAse I, protease inhibitors and 
guinea-pig liver transglutaminase were obtained from Sigma. Restriction enzymes and 
T4 DNA ligase were purchased from Bethesda Research Laboratories (BRL). 
Oligonucleotides were synthesized using a Cyclone Plus DNA synthesizer from 
Eurogentec S.A. (Seraing, Belgium). 
Construction of expression plasmids of mutant σΑ-crystallins 
The expression clone pETScoA (Merck et al., 1992), which contains the full-
length cDNA of bovine σΑ-crystallin, was used as starting material for the construction 
of σΑ-crystallin mutant clones. Mutated σΑ-crystallin constructs were made using three 
different degenerated Hhal-BamHI linkers, encoding the C-terminal amino acid residues 
to be mutated. The linkers were prepared by annealing of two complementary 
degenerated oligonucleotides. For the construction of mutant σΑ-crystallin clones (Fig. 
1A), the Xbal-Hhal insert of ρΕΤβοσΑ (544 n) and a degenerated Hhal-BamHI linker 
were cloned in Xbal-BamHI digested pGEM7Zf( + ), generating pGEM7Zf( + )aAm. 17 
out of the 19 possible mutant clones were selected by sequencing the 
pGEM7Zf( + )oAm constructs, using the Kilobase Sequence™ System (Bethesda Res. 
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Labs. Life Techn., Inc., Gaithersburg, MD/USA). The Xbal-BamHI inserts of the different 
pGEM7Zf( + )oAm clones, which encode the entire mutant σΑ-crystallins, were then 
cloned in an Xbal-BamHI digested pET8c vector resulting in the pET8coAm constructs 
1-17. Expression of wild-type and mutant σΑ-crystallins in the host E. coli 
BL21 (DE3).pLysS and preparation of the water-soluble fraction were performed 
essentially as described by Merck et al. (1992). After desalting, using Filtron Microsep 
concentrators, the watersoluble fractions were lyophilized. Expression levels of wild-
type and mutant σΑ-crystallins were measured by scanning SDS-polyacrylamide gels, 
using an LKB-Bromma Ultroscan XL Enhanced Laser Densitometer. 
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Fig. 1. Schematic representation of the full-
length cDNA for bovine aA-crystallin in pET8c 
(A). The Hhal-BamHI sequence (wt) encodes 
the 3 carboxyl-terminal amino acid residues and 
contains the translation termination codon. 
Substitution of the wild-type Hhal-BamHI 
fragment by the degenerated Hhal-BamHI 
linkers (indicated), generates mutant σΑ-
crystallins containing different carboxyl-terminal 
amino acid residues. Carboxyl-terminal amino 
acid sequences of the 17 aA-crystallin mutants 
(B). Mutants oAm1-8, jAm9-12 and oAm13-17 
were obtained using the degenerated linkers 1, 
2 and 3, respectively. 
Analysis of the transglutaminase amine-donor substrate capacity 
To study the lysine-substrate capacity of wild-type (wt) and mutant σΑ-
crystallins, water-soluble fractions of bacterial lysates, containing equal amounts of wt 
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or mutant αΑ-crystallin, were treated w i t h guinea-pig liver transglutaminase in the 
presence of a biotinylated amine-acceptor hexapeptide (H-Thr-Val-Gln-Gln-Glu-Leu-OH; 
final concentration 1.8 mM) as described by Groenen et al. (1992). The required 
amounts of the water-soluble fractions, containing wild-type or mutant σΑ-crystallins, 
were calculated from the scanning data. Samples were analysed by SDS-PAGE 
(Laemmli, 1970) fol lowed by staining w i t h Coomassie Brilliant Blue and by streptavidin 
blot analysis (Groenen er al., 1992). 
RESULTS 
The use of degenerated linkers enabled us to produce different mutant σΑ-
crystallins (oAm1-17; see Fig. 1B), all containing an introduced lysine residue in their ex­
terminai extension. Induction of the mutant pET8coAm clones in E. coli results in the 
abundant expression of a polypeptide w i t h an apparent molecular mass a little higher 
than the recombinant wild-type or native calf lens oA-crystallin subunit (Fig. 2). This 
difference in apparent molecular mass is probably due to the introduction of positively 
charged amino acid residues, because mutants 12 and 15, which contain in addition to 
the lysine also an additional arginine residue, again have a slightly«- lower mobil ity in 
SDS-PAGE than the other mutant σΑ-crystallins. Such influence of certain amino acid 
replacements on the mobility of σ-crystallin in SDS-PAGE has been described earlier (de 
Jong et al., 1978). Expression levels of the mutant σΑ-crystallins in the water-soluble 
fractions varied between 1 8 % (oAm10) and 4 5 % (oAm13), as estimated by scanning 
the Coomassie Brilliant Blue gel patterns. 
8 0 -
49.5- ;:.... 
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Fig. 2. Overexpression of mutant σΑ-crystallins in E. coli. Coomassie-Brilliant Blue-stained 
protein pattern after SDS-polyacrylamide gel electrophoresis of the water-soluble fractions of E. 
coli containing plasmids pET8coA1-17 and wild-type (wt) after induction. Mutant σΑ-crystallins 
are indicated by their numbers. Wt σΑ-crystallin induced in E. coli, E. coli proteins (E) and σ-
crystallin from calf lens cortex are loaded as controls. The lens σΑ- and oB-crystallin subunits, 
the mutant σΑ-crystallins and the molecular mass markers (M in kDa) are indicated. 
The amine-donor substrate reactivities for tissue-type transglutaminase of the 17 
C-terminally mutated σΑ-crystallins were examined via incubation of the bacterial 
lysates containing the mutant proteins, wi th transglutaminase and the biotinylated 
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amine-acceptor probe, followed by SDS-PAGE and streptavidin blot analysis. The 
endogenous bacterial proteins exhibited only limited reactivity with the probe as 
compared with the mutant oA-crystallins. Equal amounts of mutant σΑ-crystallins were 
used in the reaction mixtures and it was also attempted to load equal amounts of 
mutant σΑ-crystallins on the gels. First of all, it is clear from Fig. 3 that the 
replacement of the C-terminal serine of σΑ-crystallin (lane wt) by a lysine (lane 1) 
makes it a good substrate for transglutaminase. This oAm1 even is a much better 
substrate than calf lens oB-crystallin (lane a). Further it is clear that also mutants 
aAm2-17, in which the neighbouring residues of the introduced lysine are modified, all 
react with the amine-acceptor peptide, although to quite different extents. This method 
only gives information about the total incorporation of the biotinylated amine-acceptor 
peptide at the end of the transglutaminase reaction, and not about the course of the 
reaction, but it reveals the conspicuous influence of the residues next to the substrate 
lysine. The transglutaminase reactions and the analysis of the peptide-decorated 
products by SDS-PAGE and streptavidin blots have been performed four times (three 
times in the presence of 1.8 mM probe and once in the presence of a larger excess of 
probe, 7.2 mM) and every time the same relative reactivities have been obtained, 
showing the reproducibility of the procedure. 
Comparing orAm2, 3 and 4 with oAm1 reveals that adding a leucine С-terminally 
of the substrate lysine (aAm2) has little influence, but that an valine (oAm4) and 
especially a glycine (oAm3) at this position has an enhancing effect. By comparing 
mutant oAm5 with mutant oAm1 it appears that the replacement of the penultimate 
serine by leucine considerably reduces the substrate reactivity of the C-terminal lysine. 
This effect is much less pronounced or even abolished when leucine, glycine or valine 
are added behind the lysine residue (oAm6-8 vs. aAm2-4). Interestingly, adding a 
leucine behind the sequence Leu-Lys (oAm6 vs. oAm5) has a relatively stronger 
positive effect then adding a leucine behind the sequence Ser-Lys (oAm2 vs. oAmD. 
Also the enhancing influence of an valine (oAm8) or, even stronger, a glycine (oAm7) 
behind the substrate lysine is again very pronounced. While a leucine replacing a serine 
in front of the lysine thus has little effect when the lysine is followed by Leu, Gly or Val 
(σΑιτι6-8 vs. σΑπι2-4), the presence of a glycine before the lysine dramatically 
decreases the substrate reactivity (aAm9 vs. oAm3 or 7). A proline in front of the 
substrate lysine has a similar deleterious effect (oAm11). Interestingly, the additional 
methyl group of alanine (oAm10) greatly restores the substrate reactivity as compared 
with glycine (oAm9). Also, the presence of the bulky and positively charged arginine 
has a positive effect (σΑιπ12 vs. oAm11 or 9). The deleterious effect of glycine 
preceding the substrate lysine (aAm9) is confirmed by mutants aAm13-17, which are 
all very poor substrates. The presence of an alanine instead of a glycine on the 
carboxylic side of, and directly adjacent to the lysine, does not improve the situation 
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Fig. 3. Lysine-substrate capacity of mutant σΑ-crystallins in transglutaminase-mediated 
crosslinking. (A) Coomassie-Brilliant Blue-stained protein patterns after SDS-polyacrylamide gel 
electrophoresis and (B) the corresponding streptavidin blots. Water-soluble fractions containing 
wt and mutant σΑ-crystallins were incubated for 2 hr in a reaction mixture containing Ca'* and 
the biotinylated amine-acceptor probe without (-) or with (all other lanes) the addition of guinea-
pig liver transglutaminase. Samples are: σ-crystallin from calf lens cortex (2.5 μο in A and 3.75 
μα in B), mutant σΑ-crystallins, which are indicated by their numbers (1 μα σΑ-mutant in A and 
1.5 in B) and wild-type (wt) σΑ-crystallin from E. coli (1 μα wt σΑ-crystallin in A and 1.5 in B) 
as a negative control. Mutant oA-crystallins (oAm), peptide-decorated mutant σΑ-crystallins 
(d.oAm) and calf lens σΑ- and σΒ-crystallin are indicated; the peptide-decorated product of σΒ-
crystallin (in B) is indicated by arrows. 
(aAm13 vs. aAm9). Proline behind the substrate lysine renders the situation even 
worse (oAm14 vs. стАтЭ). Also arginine has no beneficial effect here (oAm15 vs. 
oAm9). Finally, an additional serine, as in mutants oAm16 and 17, has no detectable 
effects (compared to oAm13 and 14). 
DISCUSSION 
The question what makes a protein a suitable substrate for transglutaminase, 
either as an amine-donor or -acceptor, is important in relation with the various 
biological functions of the transglutaminases (for review: Greenberg et al., 1991). Both 
the conformational and sequential requirements for substrate glutamines and lysines in 
native proteins are poorly understood. Very few amine-donor substrate proteins have 
been characterized (Table 1). These limited data indicate that substrate lysines can be 
located at the very end of a flexible C-terminal extension (as in σΒ-crystallin and 
HSP25), in a flexible N-terminal arm (BA3-crystallin), and at various internal positions ir 
peptides or proteins (ß-endorphin, seminal vesicle protein IV, HIV glycoprotein 41 and 
Alzheimer Q/A4 amyloid protein). The location of substrate lysines obviously must make 
it accessible for the transglutaminase. The fact that σΑ-crystallin, normally not e 
substrate for transglutaminase, becomes a good substrate by the mere introduction of s 
C-terminal lysine, proves that the properties of the protein surface around the substrate 
site are not crucial. 
Up till now, very little is known about the requirements for the amine-binding 
site in acyl intermediates of transglutaminase. There is one study that describes the 
effect on substrate specificity of the location of a leucyl residue in a series of lysine-
containing heptapeptides. It was demonstrated that replacement of a glycyl residue by 
mo. 
Table 1. Comparison of amino acid sequences surrounding the lysine residue(s) that 
serve as amine-donor substrate sites for tissue-type transglutaminase. 
Substrate protein Sequence 
Seminal vesicle protein RKTKEKYSQSEEWSESFASGPSSGSSDELVADKPYGPKVSGGSFGEE 
IV (rat)1 ASEEISSRRSKHISRSSGGSNMEOESSYAjgaCRSRFAODVLN 
ß-Endorphin (human)2 YGGFMTSEKSQTPLVTLFKNAIVKNAHKKGQ 
Glycoprotein 41 (HIV)3 QARILAVERYLEDQQLLGIWGCS 
Alzheimer ß/A4 amyloid DAEFRHDSGYEVHHQELVFFAEDVGSNK 
protein4 
aB-Crystallin, bovine5 EEKPAVTAAPKK 
dogfieh DEKPAVAGPQQ5 
chicken EEKPAIAGSQRfi 
Heat Shock Protein 25 PEAGKSEQSGAK 
(mouse)6 
ЯАЗ-CryBtallin METQTVQQELESLPTTKMAQTN 
(bovine)7 
The amine-donor lysine residues are underlined and in bold. 
References: ' Porta et al., 1991; г Pucci er al., 1988; 3 Mariniello et al., 1993, 4 Ikura et al., 
1993; 6 Groenen et al., 1992; ' Merck efe/., 1993; ' Groenen et al., 1993o 
a leucyl residue on the amino side of, and directly adjacent to the substrate lysine 
causes a pronounced enhancement in reactivity (Gross et al., 1977). Our results are in 
perfect agreement with this finding (compare oAm7 and 9), and extend the observation 
that the amino acid residues directly preceding the substrate lysine have a pronounced 
effect on the substrate reactivity. Notably, we here demonstrate that not only a leucyl 
residue, but even more a seryl, alanyl or arginyl residue on the amino side of, and 
directly adjacent to the lysine substrate have a positive effect on the final reactivity 
compared to a glycyl residue. Like a glycyl -, also a prolyl residue in front of the 
substrate lysine has a deleterious effect. From our results it appears that the amino acid 
residue on the carboxylic side of the substrate lysine residue affects the relative 
substrate reactivity as well. The negative effect of a carboxyl-flanking prolyl residue on 
the substrate capacity is the strongest of all, whereas a glycyl residue is relatively 
favourable. In this respect, it may be relevant to note that none of the identified amine-
donor substrate sites in proteins is flanked by prolyl residues (Table 1). Moreover, 
substance P, a short peptide composed of 11 amino acids of which one lysine at 
position 3, was found not to be an amine-donor substrate for transglutaminase (Porta 
et al., 1988); the lysine residue of this peptide is flanked by a prolyl residue both on the 
amino - and on the carboxylic side. Also the prolyl residue preceding the two lysine 
residues in σΒ-crystallin (Table 1 ) prevents the penultimate lysine to become an amine-
donor substrate when the C-terminal lysine is removed (Groenen et al., 1992). 
However, the reactivity of oAm11 demonstrates that the presence of a prolyl residue 
on the amino side of, and directly adjacent to the substrate lysine residue, does not 
prevent in all cases the lysine from acting as an amine-donor substrate. 
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This study shows that transglutaminase has a broad tolerance towards 
accessible amine-donor substrate lysines in proteins. Our results as well as the 
comparison of the amino acid sequences surrounding the few known reactive lysine 
residues that serve as amine-donor substrates in proteins (Table 1) show that no 
consensus sequence around such lysines does exist. Yet, our data also demonstrate 
that the chemical nature of the side chains surrounding the substrate lysine has a 
pronounced effect on the substrate reacitivity. It is, may be, not too surprising that the 
structurally most influential proline and glycine residues have the greatest influence on 
the substrate capacity. However, the tertiary structure of tissue-type transglutaminase 
still being unknown, and therefore also the active site properties, makes it impossible to 
interpret the observed effects of amino acid replacements more specifically. Additional 
mutations are necessary to further explore the lysine-substrate requirements in a 
systematic manner. Moreover, the limited number of mutants included in this study 
hampers as yet broader inferences with respect to the influence of charge, bulkiness 
and polarity of the side chains. It would be particularly interesting to study the effect of 
a preceding glutamyl or aspartyl residue, because none of the reactive lysines in 
proteins is preceded by acidic amino acid residues. Additional mutants are also required 
to establish whether this enfluence of substrate lysines extends to residues not directly 
adjacent to the amine-donor. Finally, also kinetic measurements will be needed to fully 
elucidate the amine-donor substrate requirements for optimal interaction between the 
acyl-enzyme intermediate and the lysine substrate. 
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Summary / Samenvatting 

The function of the eye lens is to focus the incoming light on the retina. To 
achieve transparency and proper light refraction, the lens fiber cells have a very high 
protein concentration and the structural proteins of the lens, the crystalline, are closely 
and regularly packed. The lens fiber cells remain present during the entire life-span. As 
a consequence of its unique growth pattern and the slow protein turnover, the lens 
contains proteins in its inner region, the nucleus, which are as old as the organism 
itself. Due to this longevity, the crystalline can undergo several posttranslational 
modifications. Some of these modifications affect the charge, size, solubility or 
structure of the proteins, which may, eventually, lead to cataract. 
This thesis deals with the identification of certain site-specific posttranslational 
modifications that occur in bovine lens crystallins. These modifications include the non-
enzymatic modifications resulting from deamidation of asparagine residues and 
racemization of aspartic acid residues, and the enzyme(transglutaminase)-controlled 
crosslinking of crystallin-substrates. A survey of the most important in vivo and in vitro 
modifications that have been established for vertebrate crystallins is given in Chapter 2. 
Deamidation of asparagine residues is thought to be one of the most prevalent 
non-enzymatic modifications in aging proteins. Deamidation occurs via the formation 
and subsequent hydrolysis of a succinimide intermediate. Hydrolysis of the imide ring 
also leads to isomerization and pronounced racemization of the resulting aspartyl 
residues. The propensity to form imide rings in native proteins largely depends on the 
local conformation around the residue. Some years ago, it has been demonstrated in 
our group that bovine σΑ-crystallin undergoes site-specific age-dependent deamidation 
via formation of a succinimide intermediate. In Chapter 4 we now show that age-
dependent deamidation of a specific asparagine residue (Asn146) also occurs in bovine 
(and human) σΒ-crystallin. In vitro studies reveal that the deamidation is accompanied 
by significant racemization, which demonstrates the involvement of a succinimide 
intermediate. In vitro studies of other research groups have provided evidence that 
imide ring formation can similarly occur at aspartic acid residues, leading to their 
isomerization and racemization. Also this process takes place in aging σ-crystallin. We 
found that among the 14 aspartyl residues in σΑ-crystallin only a single one, Aspi 5 1 , 
becomes strongly racemized with increasing age (Chapter 3). Aspi 51 resides in a 
flexible carboxyl terminal extension of σΑ-crystallin, which would facilitate imide ring 
formation. The functional significance of the site-specific deamidation and racemization 
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of both σ-crystallins ¡η the lens, if any, is not yet known. 
Crosslinking of crystalline is another posttranslational event that occurs upon 
aging of the lens. Crosslinking can be achieved by the action of transglutaminase, an 
enzyme that has been demonstrated in eye lenses of several mammalian species. Ca2+-
activated transglutaminase catalyzes the formation of isopeptide bonds between the y-
carboxamide group of glutamina residues and the í-amino group of lysine residues. 
Human cataractous lenses have been shown to contain significant amounts of 
isopeptide bonds, which suggests the involvement of lens transglutaminase in the 
development of cataract. In calf lenses, the amine-acceptor glutamine-substrates have 
earlier been demonstrated in the BB2-, BB3- and ВАЗ-crystallins. Chapters 5-9 now 
deal with the identification of the amine-donor lysine-substrates among the bovine lens 
crystallins and with the analysis of amine-donor substrate-specificity of tissue-type 
transglutaminase. 
Using a newly-developed amine-acceptor peptide, we were able to identify the 
bovine lens crystallins that specifically function as amine-donor substrates for 
transglutaminase, being oB-crystallin (Chapter 5) and BB1-, ВАЗ- and BA4-crystallin 
(Chapter 7). In Chapter 7 it is also shown that the substrate-capacity of the crystallins 
that serve as amine-acceptor or amine-donor substrates is enhanced upon oxidation of 
the crystallins. This finding suggests that oxidative stress and transglutaminase activity 
may be jointly involved in the changes found in lens crystallins with age and in the 
development of cataract. 
The reactive lysine-substrate site in σΒ-crystallin (Chapter 5) and in BA3-
crystallin (Chapter 8) could also be identified. For oB-crystallin this was done by 
protein-chemical methods, whereas for BA3-crystallin site-directed mutagenesis was 
performed. Because σ-crystallin belongs to the same protein family as the ubiquitous 
small heat shock proteins, it was interesting to determine whether this protein serves 
as an amine-donor substrate as well. We found that the carboxyl-terminal lysine in the 
small heat-shock protein of the mouse, as in bovine oB-crystallin, acts as the sole 
amine-donor substrate site (Chapter 6). Very little is known about the amine-donor 
substrate-specificity of transglutaminase. It is noteworthy that the lysine-substrates, 
which we have identified, are all located in the N-terminal (ВАЗ-crystallin) or in the C-
terminal (oB-crystallin and HSP) arms, which extend from the globular two domain 
structure of the proteins and are therefore accessible for the enzyme. Protein 
engineering was performed to study the effect of the primary structure on the amine-
donor substrate-specificity. A series of oA-crystallin mutant proteins was generated, 
which contain a reactive substrate-lysine residue that is flanked by different amino acid 
residues (Chapter 9). Evidence is obtained that although certain flanking amino acids 
clearly affect the reactivity of the substrate-lysine residue, there are no strong 
sequential constraints for the amine-donor substrate specificity of transglutaminase. 
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SAMENVATTING 
De ooglens focusseert het invallend licht op het netvlies en is hiertoe volledig 
transparant. De transparantie van de ooglens wordt onder meer gewaarborgd door een 
dichte pakking en een regelmatig geordende structuur van zowel lensvezelcellen als hun 
eiwitten, de crystallines. Het bijzondere groeipatroon van de lens en de lange 
levensduur van de lensvezelcellen en hun crystallines hebben tot gevolg dat er in het 
centrale gedeelte van de lens (de kern of nucleus) eiwitten voorkomen die zo oud zijn 
als het organisme zelf. Tijdens hun bestaan kunnen de crystallines allerlei 
posttranslationele veranderingen ondergaan. Veel van deze modificaties kunnen de 
lading, grootte, oplosbaarheid of de structuur van het eiwit beïnvloeden. Als gevolg 
hiervan kan de structurele ordening van de eiwitten in de lens verstoord raken, hetgeen 
uiteindelijk kan leiden tot cataract (staar). 
In dit proefschrift wordt de identificatie van bepaalde plaats-specifieke 
posttranslatie-modificaties in runderlens-crystallines beschreven. Deze modificaties 
betreffen de niet-enzymatische veranderingen door deamidering van asparagine-residuen 
en racemisatie van asparaginezuur-residuen, alsmede de enzym(transglutaminase)-
gemediëerde crosslinking van crystallinesubstraten. In Hoofdstuk 2 wordt een 
literatuuroverzicht gegeven van de belangrijkste in vivo en in vitro modificaties die de 
afgelopen jaren in zoogdiercrystallines geïdentificeerd zijn. 
Deamidering van asparagine-residuen is één van de meest voorkomende niet-
enzymatische modificaties tijdens veroudering van eiwitten. Deamidering verloopt via 
de vorming van een succinimidering en leidt, na hydrolyse van de imidering, tevens tot 
isomerisatie en een verhoogde racemisatie van de resulterende asparaginezuur-residuen. 
Het vermogen om imide-ringstructuren te vormen in natieve eiwitten blijkt voornamelijk 
afhankelijk te zijn van de locale conformatie rondom het asparagine-residu. Eerder 
onderzoek heeft reeds aangetoond dat een specifiek asparagine-residu van runder-oA-
crystalline deamideert via de vorming van een succinimide-intermediair. In Hoofdstuk 4 
tonen we aan dat ook in runder-oB-crystalline (en tevens in humaan-ofl-crystalline) een 
leeftijds-afhankelijke deamidering optreedt van een specifiek asparagine-residu 
(Asn146). In vitro studies laten zien dat deze plaats-specifieke deamidering gepaard 
gaat met een significante racemisatie, hetgeen duidt op de betrokkenheid van een 
succinimide-intermediair. In vitro studies van andere onderzoeksgroepen hebben 
aangetoond dat ook asparaginezuur-residuen succinimide-ringstructuren kunnen 
vormen, hetgeen leidt tot isomerisatie en racemisatie van de betreffende residuen. Dit 
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proces lijkt tevens op te treden tijdens veroudering van σ-crystalline. Wij hebben 
aangetoond (Hoofdstuk 3) dat er een specifieke leeftijdsafhankelijke racemisatie 
optreedt bij één van de 14 asparaginezuur-residuen van σΑ-crystalline, namelijk bij 
Aspi 5 1 . Verondersteld wordt dat de ligging van Aspi 51 in de flexibele carboxy-
terminale regio van σΑ-crystalline, de hoge racemisatie via imide-ringvorming mogelijk 
maakt. De functionele betekenis van de plaats-gerichte deamidering en racemisatie van 
beide σ-crystalline ketens in de lens, als die er al is, is niet bekend. 
Gedurende de veroudering van de lens treedt tevens crosslinking van crystallines 
op. Eén van de manieren waardoor crosslinking bewerkstelligd kan worden is via 
transglutaminase, een enzym dat in ooglenzen van verscheidene zoogdieren is 
aangetoond. Ca2+-geactiveerd transglutaminase katalyseert de vorming van isopeptide 
bindingen tussen de f-carboxamide groep van glutamine-residuen en de e-amino groep 
van lysine-residuen. Aangezien de isopeptide-crosslinkingsproducten aangetoond zijn in 
cataracteuze lenzen van oude mensen, is gesuggereerd dat het lenstransglutaminase 
betrokken zou zijn bij de ontwikkeling van cataract ten gevolge van ouderdom. In 
kalverlenzen werden al eerder de amine-acceptor-glutaminesubstraten in BB2-, BB3- en 
BA4-crystalline geïdentificeerd. In Hoofdstukken 5-9 wordt de identificatie van de 
amine-donor-lysinesubstraten in de lens beschreven en wordt de amine-donor-
substraatspecificiteit van transglutaminase nader geanalyseerd. 
Met behulp van een nieuw-ontwikkeld amine-acceptorpeptide zijn we erin 
geslaagd om de amine-donor-lysinesubstraten in de lens te identificeren. Het blijkt dat 
er van alle water-oplosbare eiwitten in de lens slechts 4 crystallines als amine-donor-
substraat fungeren, namelijk oB-crystalline (Hoofdstuk 5) en BB1-, ВАЗ-, BA4-
crystalline (Hoofdstuk 7). In Hoofdstuk 7 wordt tevens beschreven dat de substraat­
capaciteit van de crystallines die glutamine- of lysine-substraat zijn, toeneemt na 
oxidatieve behandeling van de crystallines. Deze bevinding suggereert dat oxidatieve 
stress en transglutaminase-activiteit tesamen betrokken zijn bij de veranderingen die 
crystallines ondergaan tijdens veroudering en tijdens de ontwikkeling van cataract. 
We zijn er ook in geslaagd om het reactieve substraat-lysineresidue in oB-
crystalline en in ВАЗ-crystalline te identificeren. Voor oB-crystalline werd dit gedaan via 
de eiwit-chemische weg (Hoofdstuk 5) terwijl voor ВАЗ-crystalline plaatsgerichte 
mutagenese werd toegepast (Hoofdstuk 8). Omdat een aantal jaren geleden werd 
ontdekt dat σ-crystalline tot dezelfde eiwitfamilie behoort als de kleine 'heat-shock' 
eiwitten (HSP), was het interessant om na te gaan of het muis HSP25 ook een amine-
donorresidue is voor transglutaminase. We hebben aangetoond dat de carboxy-
terminale lysine in muis HSP, net zoals in oB-crystalline, als enige amine-donorsubstraat 
fungeert (Hoofdstuk 6). Over de amine-donorsubstraatspecificiteit van transglutaminase 
is nagenoeg niets bekend. Opvallend is dat de door ons geïdentificeerde substraat-
lysineresiduen allemaal gelocaliseerd zijn in de N-terminale (BA3-crystalline) of C-
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terminale (αβ-crystalline en HSP) armen, welke uitsteken vanuit de globulaire 
eiwitdomeinen en daardoor klaarblijkelijk toegankelijk zijn voor transglutaminase. Om te 
bepalen of de primaire structuur ook effect heeft op de amine-donorspecificiteit van 
transglutaminase werd protein engineering toegepast, een techniek waarmee specifiek 
één of meerdere aminozuren door andere residuen vervangen kunnen worden. Er werd 
een serie oA-crystalline-mutanteiwitten gemaakt, allen met een reactief substraat-
lysine-residue (in de carboxy-terminale regio) dat geflankeerd wordt door verschilende 
aminozuurresiduen (Hoofdstuk 9). Wij hebben aanwijzigingen dat de flankerende 
aminozuren de reactiviteit van de substraat-lysine sterk beïnvloeden. Uit de verkregen 
resultaten en uit de vergelijking van aminozuursequenties rondom geïdentificeerde 
substraat-lysines in eiwitten blijkt tevens dat er geen consensus sequentie is voor de 
amine-donorsubstraten van transglutaminase. 
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